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Abstract 
 
Aging of skeletal muscle is typically accompanied by declining regenerative potential, 
due in part to alternations in the resident muscle stem cell population, known as satellite cells. 
Previous data suggest that highly regenerative satellite cells in young mice are damaged by 
aging and chronic inflammation, driven in part by the transcription factor NF-κB. Interestingly, 
myogenic function of aged satellite cells can be restored by exposure to blood-borne factors 
from young mice, in association with decreased expression of many of pro-inflammatory genes.  
These observations led me to hypothesize that strategies counteracting the chronic 
inflammatory state in muscle might improve regenerative function in old age through 
enhancement of satellite cell function. To test this hypothesis, this study aims to define the 
molecular factors that promote chronic muscle inflammation with aging, evaluate their impact on 
satellite cell functions, and determine whether inhibition of the inflammatory process indeed 
reverses age-related muscle dysfunction. Utilization of well-established mouse models reveals 
that NF-κB activity has a detrimental effect on satellite cell function via non-cell-autonomous 
mechanisms, and that inhibition of NF-κB activity and its downstream target phospholipase A2 
in skeletal muscle fibers preserves muscle regenerative potential in aged animals.  In addition, 
this study reports the restrictive role of IL-6, a pro-inflammatory cytokine widely recognized as a 
biomarker of chronic inflammation, on the myogenic function of satellite cells. Finally, this study 
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shows that systemic inhibition of inflammation using the NF-κB antagonist sodium salicylate 
decreases inflammatory gene expression, including IL-6, in aged muscle and improves muscle 
regeneration after injury.  
Thus, chronic inflammation in muscle, in association with elevated NF-κB activity and its 
downstream pro-inflammatory factors, impairs muscle regeneration by extrinsically limiting the 
myogenic function of satellite cells in aged animals. Importantly, such impairment was shown to 
be reversible by reducing the inflammatory tone both at tissue and systemic level. By 
discovering the molecular mediators NF-κB signaling in muscle, this study provides potential 
therapeutic avenues for elderly patients with declining muscle mass and function. 
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Population Aging 
Aging is a universal, natural biological process attributed to cumulative changes in 
molecular and cellular structures that disrupt organismal homeostasis over the passage of time. 
As a result, aging animals experience progressive decline in tissue function and impaired 
regeneration, which cause functional limitations and increased vulnerability for chronic diseases, 
disability and mortality (Seals, 2015). Medical advances and socioeconomic development in the 
20th century have greatly improved global health status and increased life expectancy. In the 
past 100 years, global life expectancy has nearly doubled, from 34 to 67 (Riley, 2013). As this 
trend continues, the composition of the world’s population is expected to show a proportionate 
shift from younger to older people. The worldwide numbers of those aged 60 and above will rise 
to 21% of population by 2050, comprising the same percentage of the population as those 
under age 15 (Harper, 2014). The proportion of older adults will be even higher in developed 
countries; at least 25% of the population will be older than 65 years of age by the year 2050, 
with some regions exceeding 40% (Lutz, 2008; Petsko, 2008).  
Since aging itself is a risk factor for a myriad of diseases that range from 
neurodegenerative disorders to osteoporosis and cancer, rapid aging of the world’s population 
presents certain socio-economic challenges, such as greater caregiving and financial burden for 
families, demand for residential housing and pressure on government health insurance 
programs (Olshansky, 2009; Beard, 2014; Harper, 2014). Moreover, the speed of population 
aging is projected to accelerate in the next century with further increases in life span and 
decreases in fertility. As of 2010, the United States houses over forty million people above the 
age of 65, and this number is expected to more than double by 2050, with the greatest rate of 
increase in the oldest population aged 80 or over (Vincent, 2010). Current demographic trends 
in the U.S indicate that the U.S. Social Security Administration may be underestimating the 
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increase in life expectancy between the present and 2050 by up to 7.9 years, resulting in a 
possible unanticipated $1.7 trillion to $4.4 trillion increase in Social Security costs (Olshansky, 
2009).  
In light of the considerable burden population aging places on society, it is no wonder 
that research into aging and its effects has virtually exploded in the past thirty years. In 1980, 
James Fries proposed “compression of morbidity” as a promising strategy to address the 
problem. His proposal suggests that the cost of extended life span could be reduced by 
redirecting the focus of health improvement to postponing the age of onset of chronic diseases 
rather than surviving longer, in order to minimize the amount of disability and the span of 
morbidity before the natural occurrence of death (Fries, 1980). More recently, leading scientists 
in the field of biological aging research have adopted the idea of compression of morbidity and 
promoted the concept of healthy aging, which aims for the extension of “healthspan.” (Kirkland, 
2009; Seals, 2014). The general goal is to live long, but with good health and high quality of life. 
Age-associated physiological dysfunctions are a major obstacle for maintaining quality of 
life into old age. In particular, loss of muscle strength can affect overall quality of life by limiting 
motility and the ability to perform basic activities of daily living, often leading to more adverse 
consequences such as falls, fractures, even mortality (Hanna, 2015). In fact, loss of muscle 
mass and strength is thought to be a major contributor to the development of frailty, a common 
clinical syndrome in older adults that carries an increased risk for poor health outcomes (Xue, 
2011; Clegg, 2011).  
Based on these observations, I seek to focus specifically on the effect of systemic aging 
on skeletal muscle in this research, by probing the molecular mechanism(s) that may serve as a 
fundamental cause of age-related decline in skeletal muscle function. This study aims for a 
better understanding of muscle aging, which will ultimately contribute to the development of 
therapeutic strategies for healthy aging. 
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Sarcopenia: Aging of Skeletal Muscle 
One of the major effects of aging is a decline in tissue regeneration after damage.  This 
is especially true in the case of skeletal muscle, which loses the ability to repair itself later in life 
(Grounds, 1998; Wagers, 2005). Skeletal muscle, a self-repairing tissue that allows for precise 
movement, coordination, and force production, makes up over 30% of the human body by 
weight (Janssen, 2000). The decrease in regenerative potential of skeletal muscle and reduction 
in muscle tissue quality inevitably results in sarcopenia, an age-dependent loss of muscle mass 
and function. Sarcopenia is characterized by progressive muscle atrophy, with an estimated 
0.5%-1.5% loss of muscle mass each year starting from the age of 50, an increased fat:muscle 
ratio, and changes in muscle architecture and neuromuscular junctions (Ryall, 2008).  
Sarcopenia exhibits itself in debilitating traits such as a stooped posture and weakness that 
increase risk for incident disability, all-cause mortality, mobility disability, and loss of 
independence, affecting about 40% of people over the age of 80. Furthermore, sarcopenia is 
frequently observed in association with other age-related chronic diseases such as type II 
diabetes, osteoporosis, cancer and obesity, exacerbating these pathological states (Dutta, 1997; 
Kim, 2009). Prevalence of sarcopenia continues to increase as the global population ages; 
however, currently there are no treatment options for this disease (Baumgarner, 1998). 
Multiple, interrelated factors contribute to the development and progression of 
sarcopenia. Physical inactivity due to illness or hospitalization, altered hormonal status 
(decreased levels of testosterone, androgen, growth hormones), insufficient dietary nutrients 
due to decreased food intake and dysregulation of appetite, changes in the circulating levels of 
catabolic inflammatory mediators, and inefficient protein synthesis have been postulated as 
major factors involved (Doherty, 2003; Fielding, 2011). Also, age-related loss of motor units, 
changes in structural and functional integrity of the neuromuscular junction and functional 
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denervation have been well documented to promote muscle weakness and fatigue, preceding 
muscle wasting associated with sarcopenia (Belluardo, 2001; Jang, 2011; Gutmann, 1973). At 
the cellular level, sarcopenia manifests with a reduction in the size of each individual myofiber 
and of the total number of myofibers, multi-nucleated cells that serve as individual components 
of skeletal muscle (Faulkner, 2007). Decreased myofiber size in aged skeletal muscle is 
followed by a loss of myonuclei per unit length of myofiber (Brack, 2005), and decreased 
number of myonuclei led to a hypothesis that sarcopenia may be caused by loss of muscle stem 
cells, or commonly referred to as satellite cells. In fact, cross-sectional analyses on the 
characteristics of skeletal muscle in elderly men showed positive correlations among the cross-
sectional area of type II myofibers (fast-twitch muscle fibers), myonuclear content, and satellite 
cell content, providing further support to the idea that satellite cell content plays an important 
role in regulating myofiber size, muscle mass and strength in older men (Verdijk, 2010). Also a 
recent study revealed severely impaired regeneration and increased muscle fibrosis in 
sedentary adult mice with inducible, life-long reduction of satellite cell population, proving the 
requirement of satellite cell in muscle regeneration (Fry, 2015). 
 
Age-dependent decline in stem cell functionality of satellite cells  
Satellite cells are known to enable muscle regeneration by proliferating and 
differentiating into myoblasts in response to muscle injury, but are otherwise mitotically 
quiescent (Montarras, 2005; Sambasivan, 2011).  Myoblasts differentiated from satellite cells 
during muscle regeneration are incorporated into existing myofibers or fuse with others to form 
new myofibers (Schultz, 1985; Bischoff, 1994) (Figure 1). Also, the residual pool of quiescent 
satellite cells is maintained for additional rounds of regeneration by symmetric and asymmetric 
self-renewal of satellite cells (Moss, 1971;!Kuang, 2007). The presence of satellite cells was first 
discovered by Alexander Mauro in 1961, who noticed its unique placement on the sarcolemma 
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and under the basal lamina, two thin membranes that surround myofibers (Mauro, 1961).  
Satellite cells have since been characterized as unipotent adult muscle stem cells.   
 
 
 
Satellite cells are characterized by expression of the paired-box transcription factor 
Pax7, Pax3, and myogenic regulatory factor Myf5 (Buckingham, 2007;  Seale, 2000;!Cornelison, 
1997). Although multiple studies have reported heterogeneous expression of Pax3 and Myf5 in 
satellite cells, Pax7 is considered to be the canonical biomarker of satellite cells as it is 
expressed in quiescent and activated, proliferating satellite cells across multiple species (Sacco, 
2008; Yin, 2013). Pax7 also functions as a regulator of satellite cell survival, proliferation, and 
prevents precocious differentiation of myogenic progenitor cells (Oustanina, 2004; Relaix, 2006; 
Zammit, 2006).  
Several groups including the Wagers lab have reported age-associated reduction in the 
number of satellite cells and hypothesized that this loss of satellite cells ultimately contributes to 
the aged muscle phenotype (Collins, 2007; Shefer, 2010; Sinha, 2014).  Other studies have 
demonstrated that effective muscle regeneration hinges on the presence of satellite cells, 
making this hypothesis highly plausible (Sambasivan, 2011; Lepper, 2011).  In addition, the 
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Wagers Lab and several other groups have found that the satellite cells still remaining in aged 
muscle fail to respond adequately to muscle injury and have reduced myogenic potential (Sinha, 
2014; Sousa-Victor, 2014; Cosgrove, 2014).  For better understanding of the mechanisms 
underlying this age-related process of muscle loss, active investigation into the phenomena of 
sarcopenia has been conducted in the field.    
Aging of satellite cells can be attributed to age-related changes at many levels.  It has 
been suggested that the decline in stem-cell functionality of satellite cells with age may be 
caused by intrinsic molecular changes in aged muscle stem cells or extrinsic changes due to the 
aging of the local microenvironment (e.g. myofibers and the extracellular matrix) or the systemic 
environment (e.g. changing levels of cytokines in the circulatory system) (Rando, 2006).  Since 
satellite cells exist predominantly in a quiescent state, it is likely that they exhibit a weaker 
stress response and lower levels of DNA damage repair proteins that are characteristic of non-
dividing cells, thereby accumulating excessive oxidative damage and protein aggregates over 
time (Bohr, 2002).  The intracellular amassment of damage can then lead to cellular 
senescence or apoptosis, reducing the pool of available satellite cells and thus inhibiting 
effective muscle regeneration (Sousa-Victor, 2014).  
Multiple groups have made use of the parabiotic model, in which the circulatory system 
of two animals are connected, to show that aged progenitor cells can be rejuvenated 
extrinsically, by exposure to a young systemic environment (Conboy, 2005; Sinha, 2014). In 
particular, decreased Notch signaling and the ensuing excess expression of the circulating 
growth factor TGF-β have been implicated in the failure of muscle stem cells to activate in 
response to injury (Carlson, 2009). Carlson et al. demonstrated that this reduction in 
regenerative potential can be reversed by activating MAPK/Notch in an in vitro study using 
cultured human muscle stem cells (Carlson, 2009). These studies suggest that age-associated 
loss of regenerative potential in skeletal muscle results from loss or dysfunction of muscle stem 
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cells and that restoration of proper stem cell activity would rejuvenate regenerative function in 
aged muscle. 
 
Inflamm-aging: Chronic Inflammation in the Elderly  
An important systemic change that is thought to have a profound role in the aging 
process is chronic, low-grade inflammation, characterized by persistently elevated serum levels 
of pro-inflammatory cytokines even without overt infection. Inflammation is beneficial as an 
acute, transient response to injury or pathogens, but chronic inflammation has been found in 
close relation to many age-related diseases, including Parkinson’s, Alzheimer’s, cancer, 
diabetes, arthritis and sarcopenia (Di Iorio, 2006; Sarkar, 2006; McGeer, 2003; McGeer, 2004).  
The detrimental effects of chronic inflammation are mediated by the immune system in a 
process has been termed, “inflamm-aging” (Franceschi, 2000).  Franceschi et al (2007) argue 
that inflamm-aging is evidence for a theory of aging called antagonistic pleiotropy, in which the 
expression of genes favorable at a young age are no longer beneficial at an old age, resulting in 
a decline in tissue function.  Antagonistic pleiotropy calls for an evolutionary perspective on 
aging. From this point of view, the human immune system was evolutionarily selected and 
perfected to combat acute infections in youth in order that a child might live long enough to 
reproduce.  However, with the advancement of agricultural, industrial, and medical technologies, 
Homo sapiens are living longer and longer, with immune systems unfit to deal with chronic 
diseases. The aging process is simultaneously accompanied by characteristics that accelerate 
the pro-inflammatory signals and counteracting anti-inflammatory characteristics. The balance 
between these opposite features controls the outcome of the aging process, either leading to 
frailty and degenerative diseases or a healthy old age and longevity. In the process of inflamm-
aging, adaptive immunity declines, and the anti-inflammatory mechanisms are thought to be 
insufficient and ill-equipped to deter inappropriately activated innate immune responses, 
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resulting in mild hyper-activity of circulating inflammatory factors. However, the precise etiology 
of inflamm-aging and its potential causal role in contributing to adverse health outcomes are still 
under investigation. 
In addition to age-dependent changes in the immune system, there are a number of 
potential drivers of inflamm-aging, which are also closely related to one another (Franceschi, 
2014). Accumulation of damaged macromolecules and cellular components constantly causing 
the initiation of immune response has been proposed as a potent contributor of chronic 
inflammation. Reactive molecules generated in aged cells over time as a byproduct of normal 
metabolism or from extrinsic paracrine and endocrine mediators are thought to drives a vicious 
cycle that causes damages to nucleic acids, proteins, and lipids, and disrupts mitochondrial 
oxidative phosphorylation, producing additional metabolic byproducts (Harman, 1975). As a 
response to the cellular damages and stress, aged cells readily undergo senescence, which is 
also considered to drive aging and age-associated pathologies through its secretory phenotype 
known as senescence-associated secretory phenotype (SASP) (Campisi, 2007; Baker, 2011). 
As SASP includes numerous pro-inflammatory cytokines, accumulation of senescent cells in 
aged animals could trigger chronic inflammation. 
These stimulators of chronic inflammation converge on few molecular pathways such as 
activation of NLR family-pyrin domain containing 3 (Nlrp3) inflammasome and nuclear factor κB 
(NF-κB) (Iyer, 2013; Bollrath, 2009). In particular, activation of the NF-κB pathway has been 
known as a transcriptional signature of chronic inflammation in aged skin, skeletal muscle, 
bone, and nervous system (de Magalhães, 2009), although the direct effects of NF-κB activation 
on the stem cell function in these tissues is still under investigation. Considered a common 
mediator of the various inputs and responses to cellular damage, NF-κB is activated by most 
inflammatory agents. Salminen et al. (2008) claim that NF-κB is the culprit of “inflamm-aging” 
through its effects on circulating levels of pro-inflammatory cytokines, such as interleukin 6 (IL-
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6), a common biomarker of inflammatory status and a hallmark of chronic morbidity. IL-6 is also 
associated with and predictive of many aging phenotypes, for example, changes in body 
composition, energy production and utilization, metabolic homeostasis, immune senescence, 
and neuronal health (Franceschi, 2014).  
 
Reversing Aging by Restoring Stem Cell Function 
Strong evidence that aging of stem cells involves dominant signals from the local and 
systemic environment comes from studies in mice in which surgical and genetic systems have 
been used to modulate the aged tissue and systemic milieu. In particular, exposure of old 
skeletal muscle to a youthful systemic environment through heterochronic parabiosis can 
promote efficient satellite cell activation in old muscle (Conboy, 2005). This surgical intervention 
also enhances rates of neurogenesis, remyelination and other measures of neural function in 
the old parabiont, suggesting that changes in stem cell function in the aging central nervous 
system are also affected by blood-borne factors (Vileda, 2011; Katsimpardi, 2014; Ruckh, 
2012). Intriguingly, at least part of the ‘rejuvenating’ effect of a young systemic environment 
appears to relate to the higher levels of circulating growth differentiation factor 11 (GDF11) and 
oxytocin present in young blood as compared to aged (Sinha, 2014; Katsimpardi, 2014; Loffredo, 
2013; Elabd, 2014). Treatment of aged mice with either recombinant GDF11 or oxytocin 
reverses dysfunction of aged satellite cells and restores robust regenerative function in aged 
mice (Sinha, 2014; Elabd, 2014). GDF11 supplementation in old mice further reverses age-
related hypertrophy in cardiac muscle (Loffredo, 2013), enhances neural stem cell and neuronal 
function (Katsimpardi, 2014) and improves physical activity (Sinha, 2014). These studies raise 
the possibility that manipulation of blood-borne factors could provide a particularly attractive 
strategy for the treatment of age-related muscle disease. 
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In addition to systemic factors, improving protein homeostasis could also help restore 
stem cell function. Up-regulation of pro-autophagy genes by FOXO3A was shown to be 
essential for protecting aged HSCs from metabolic stress (Warr, 2013). Pharmaceutical 
inhibition of mTOR has been reported to facilitate autophagosome formation (Nazio, 2013; Kim, 
2011) and also to restore the self-renewal and hematopoietic potential of aged HSCs 
(Chen,2009). Likewise, data from mice genetically manipulated to preserve chaperone-
mediated autophagy (CMA), a form of autophagy involving chaperone-dependent selection of 
substrates, showed improved cellular homeostasis, enhanced resistance to stressors and 
preservation of organ functions with age (Zhang, 2008). Overexpression of heat shock protein 
70 (HSP70), a chaperone protein that recognizes damaged proteins in CMA, also protects 
against age- and disease-related tissue degeneration in brain, heart and skeletal muscle 
(Cummings, 2001; Feng, 2014; McArdle, 2004). These studies provide intriguing insights into 
potential therapeutic interventions for age-related dysfunction, although the specific role, if any, 
of CMA and chaperone proteins in stem cell aging is a subject for future research. 
 
In this study, I hypothesize that chronic inflammation is a main contributor to satellite cell 
dysfunction in aging, and aim to understand the underlying mechanism by defining molecular 
factors involved in age-associated chronic inflammation in skeletal muscle. In particular, the NF-
κB pathway is assessed as a major mediator of chronic inflammation. Utilizing genetic and 
pharmacological modulation of NF-κB activity in muscle tissue or in the whole body of mice, this 
study demonstrates the impact of NF-κB-mediated chronic inflammation on the functionality of 
muscle stem cell and its niche. Furthermore, this study examines the reversal of chronic 
inflammation as a strategy to restore myogenic regenerative potential and limit age-related 
muscle loss. 
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Chapter 2.   
NF-κB mediates chronic inflammation in aged muscle and  
impairs muscle stem cell niche 
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Preface 
In skeletal muscle, age-associated loss of regenerative potential results in delayed or 
deficient myogenesis, replacing damaged muscle fibers with fat and fibrous tissue rather than 
newly formed muscle (Conboy, 2005a) and slowing recovery of muscle function (Blau, 2014). 
The mechanisms underlying age-related muscle dysfunction remain incompletely understood, 
but some studies have implicated loss or functional impairment of satellite cells within aged 
muscle (Sherwood 2004; Conboy 2003). Notably, age-related decline in satellite cell myogenic 
potential appears to be reversible, as demonstrated by improved muscle regeneration following 
heterochronic parabiosis, or systemic administration of growth differentiation factor-11 or 
oxytocin (Conboy, 2005b; Sinha, 2014; Conboy, 2014). 
   One possible cause for deficient satellite cell function in aged muscle is an increase in 
skeletal muscle inflammation, which may be mediated in part by increased transcriptional 
activity of NF-κB (Barnes, 1997; Cai, 2004; He, 2013). Studies of aged and sarcopenic humans 
support the association of increased “inflammatory tone” in muscle with reduced physiological 
function (Barnes, 1997).  Studies in mice also support the notion that a pro-inflammatory 
microenvironment may limit repair potential in aged muscle (Tierney, 2013, Oh, 2014).   
NF-κB is a transcription factor that plays a central role in modulating multiple systemic 
and cellular functions, including inflammation, immunity, cell survival, and proliferation (Karin, 
2006). Inactive NF-κB remains in the cytoplasm bound to inhibitor of kappaB (IκB); however, IκB 
kinase b (IKKb) becomes activated in response to pro-inflammatory factors, including tumor 
necrosis factor alpha (TNFα) and IL-6, and subsequently phosphorylates IκB, leading to its 
ubiquination and degradation (Hayden, 2004). Degradation of IκB releases NF-κB, which 
translocates to the nucleus and transcriptionally upregulates pro-inflammatory effector genes. 
NF-κB activity is transiently regulated under normal physiological conditions, but constitutive 
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activation of NF-κB has been observed in several disease states, including muscle wasting and 
muscular dystrophy (Li, 2008; Cai, 2004;  Acharyya, 2007). 
NF-κB activation has been shown to inhibit MyoD expression and thereby repress 
myofiber formation in culture (Guttridge, 2000; Langen, 2004).  Yet, how NF-κB may function to 
regulate skeletal muscle regeneration in vivo is not as well understood.  Furthermore, although 
increased NF-κB activity is associated with sarcopenia (Bar-Shai, 2005; Giresi, 2005; Cai, 
2004), its role in aging-associated satellite cell dysfunction has not been clarified.  In this 
chapter, I analyze changes in NF-κB activity that occur with skeletal muscle aging, examine the 
relevance of NF-κB signaling in skeletal muscle satellite cell function and muscle regeneration, 
and determine whether pharmacologic inhibition of NF-κB can improve muscle repair activity 
through stimulation of satellite cell function.  
  
Results 
Satellite cell frequency and survival decrease with aging.  
Satellite cells in this study were isolated by fluorescence-activated cell sorting (FACS) as the 
CD45-Sca1-Mac1-CXCR4+β1integrin+ subset of myofiber associated cells, as previously 
described (Sherwood, 2004; Cerletti, 2008). Representative FACS schemes for isolation of 
young and aged satellite cells are shown in Figure 2. For evaluation of stem cell functionality of 
satellite cells in young and old mice, frequency of satellite cell and myogenic colony formation 
potential was analyzed. Satellite cell frequency was calculated as percentage of CD45-Sca1-
Mac1-CXCR4+β1integrin+ population in myofiber-associated cells that are positive for cell 
vaiability marker, calcein blue. For myogenic colony formation assay, single satellite cell was 
seeded into each well of 96-well culture plates and was allowed to form colony. After isolation 
and culture, single satellite cell is activated rapidly to expand and transition to the progenitor 
stage to undergo myogenic lineage progression. At day 5 of culture, number of myogenic colony  
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was counted to assess myogenic colony formation efficiency as a measure of satellite cell’s 
ability to survive and proliferate to form myogenic colony in response to signals that stimulate 
myogenesis (Cerletti, 2008; Cerletti, 2012; Sinha, 2014). Satellite cell frequency within the 
myofiber-associated cell pool and myogenic colony forming potential are greatly decreased in 
aged mice (n=12) as compared to young (n=9, Figure 3a,b). These data are consistent with 
previously reported studies from our lab (Cerletti, 2012; Sinha, 2014) and others (Conboy, 
2005).  Electrophoretic mobility shift assays (EMSA) confirmed that these differences in satellite 
cell activity are associated with an overall increase in NF-κB activity in aged skeletal muscle 
! 17!
(n=8) compared to young skeletal muscle (n=6, Figure 3c,d). Consistent with enhancement of 
NF-κB activity in aged satellite cells, many genes that are either direct targets or activators of 
the NF-κB pathway, including IL-6, IL-33, chemokine-chemokine ligand (Ccl)-2, and cyclo-
oxygenase (Cox)-2 showed transcriptional upregulation in satellite cells isolated from aged as 
compared to young controls (n=4-6, Figure 3e). Importantly, while prior studies have reported 
increased NF-κB activity in sarcopenic muscle (Giresi, 2005; Barnes, 1997), this study is the 
first, to my knowledge, that correlates an upregulation of NF-κB activity with increased 
expression of pro-inflammatory cytokines and decreased myogenic potential specifically in 
satellite cells.  
 
Satellite cell-specific activation of NF-κB activity reveals a non cell-autonomous effect of 
NF-κB on satellite cell function.  
To determine if increased NF-κB activity in satellite cells might directly cause impairment 
of their regenerative function, I next developed a novel Cre-lox transgenic mouse, engineered to 
activate NF-κB upon administration of tamoxifen. Experimental animals for this study were 
generated by breeding mice carrying a tamoxifen-inducible CreER allele driven from the 
endogenous Pax7 locus (Nishijo, 2009) with mice carrying a loxP-STOP-loxP IKKb and green 
fluorescent protein (GFP) reporter allele controlled by the ubiquitously expressed Rosa26 
promoter and linked by an internal ribosome entry site (IRES) (Figure 4a). Transgenic animals 
resulting from these crosses enable satellite cell-specific activation of NF-κB signaling by virtue 
of Cre-dependent expression of a constitutively active IKKb only in Pax7+ cells, which ensures 
continuous degradation of IκB and release of NF-κB from its inhibitory complex (Sasaki, 2006).  
I have called these animals SC-IKK mice for ‘satellite cell’ specific IKKb production.  FACS 
analysis of myofiber-associated cells harvested from SC-IKK mouse muscle 4 weeks after 
tamoxifen treatment demonstrated that 61.8% (±6.4%, n=8) of immunophenotypically identified 
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satellite cells were GFP+, indicating Cre-induced activation of expression of the IKKb-IRES-GFP 
reporter (Figure 4b). Cell populations of other lineage (fibro-adipogenic, and hematopoietic) 
were not GFP+ (data not shown). 
To evaluate the impact of constitutive NF-κB signaling in satellite cells on satellite cell 
phenotype and function, I first examined the frequency and function of these cells in SC-IKK 
mouse muscle 4 weeks after tamoxifen administration.  qRT-PCR analysis demonstrated high 
levels of inflammatory gene expression in satellite cells harvested from these mice (n=5, Figure 
5a). However, in contrast to my hypothesis that activation of NF-κB in satellite cells might cause 
functional impairment of satellite cells, SC-IKK satellite cells exhibited no change in the overall 
frequency of satellite cells isolated from young tamoxifen-treated SC-IKK mice (n=8, Figure 5b) 
and no difference in the ability of these cells to initiate clonal myogenic cell growth in culture  
(n=8, Figure 5c). Thus, tamoxifen-dependent transgenic induction of NF-κB activity in SC-IKK 
satellite cells, while sufficient to upregulate NF-κB target genes, does not appear to cause 
disruptions in satellite cell number or intrinsic myogenic function.  On the other hand, when 
challenged by muscle injury, SC-IKK mice demonstrated a clear deficit in muscle regeneration, 
evidenced by reduced cross-sectional area of newly formed myofibers (marked by central 
nuclei, n=7, Figure 5d,e). SC-IKK muscle also showed a decrease in total area of muscle 
regeneration, with more necrotic fibers and infiltrating inflammatory cells remaining as compared 
to WT controls at the same time point after injury (Figure 5d, Supplemental figure 1).  
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These seemingly contradictory results can be explained if the activated NF-κB exerts its 
detrimental effect in a non-cell-autonomous fashion. In this model, activation of NF-κB in 
satellite cells would not affect the cells directly, but when those satellite cells are activated and 
undergo myogenic differentiation to contribute their nuclei to myofibers, they produce an NF-κB-
activated microenvironment that can secrete inflammatory signals and indirectly affect muscle 
stem cell function, causing impaired muscle regeneration. It is also possible that NF-κB only 
affects later stages of myogenesis, in which myoblasts fuse to form myotubes and grow in size, 
either intrinsically or extrinsically. NF-κB-induced loss of MyoD messenger RNA in the C2C12 
myoblasts studied by Guttridge et al. (2000) supports the latter explanation, although the 
specific timing during skeletal muscle development at which NF-κB plays its role is yet to be 
clarified. In addition, cell culture of SC-IKK satellite cells showed a trend towards decreased 
differentiation potential compared to WT controls, as assessed by the number of fusion events 
and size of myotubes, consistent with the notion that constitutive activation of NF-κB in satellite 
cells can negatively influence the myogenic differentiation of these cells or their progeny 
(Supplemental figure 2). 
 
NF-κB-activated niche causes deficits in satellite cell function in young and mid-aged 
mice.  
To test the aforementioned model of non-cell autonomy of the effect of NF-κB in muscle, 
I examined the myogenic function of satellite cells isolated from injured muscles of SC-IKK 
mice. Upon injury, satellite cells of SC-IKK muscle will be activated and differentiate to 
regenerate myofibers, such that these progeny of SC-IKK satellite cells eventually form a niche 
with activated NF-κB signaling. Satellite cells from injured SC-IKK muscle indeed showed 
decreased myogenic efficiency compared to those from injured WT muscle, whereas satellite 
cells of uninjured SC-IKK muscle did not differ from those of uninjured WT muscle (n=5, Figure 
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6a). Also, prolonged satellite cell-specific NF-κB activation deteriorated the myogenic function of 
satellite cells. After 6-9 months of satellite cell-specific NF-κB activation, SC-IKK mice showed a 
more rapid decline in colony formation efficiency and muscle regeneration after cryoinjury than 
age-matched WT controls (n=4-5, Figure 6b,c). This result likely reflects the formation of an NF-
κB-activated niche over time due to gradual accretion in muscle fibers of IKK-expressing 
satellite cell nuclei, as satellite cells are spontaneously activated from wear and tear to maintain 
the muscle homeostasis. This altered niche then acts indirectly to impair satellite cell function in 
SC-IKK muscle. 
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Muscle-specific inhibition of NF-κB activity improves satellite cell function in an aging 
model.   
Taken together, the data reported above are consistent with a model in which cell type-
specific activation of NF-κB signaling in aged muscle fibers, rather than aged satellite cells, is 
the primary cause of deficient muscle regeneration in older animals. To further test this notion, I 
examined satellite cell and muscle regenerative function in aged animals harboring a transgene 
that constitutively blocks NF-κB signaling in skeletal muscle. Muscle-specific IkB super-
repressor (MISR) mice (Figure 7a) constitutively express the IkB super-repressor in skeletal 
muscle fibers, and have been reported to exhibit nearly complete inhibition of NF-κB activity in 
mature myofibers of young (8-11 weeks of age) mice (Cai, 2004).  I confirmed NF-κB inhibition 
by the MISR transgene in aged (24-26 months of age) mice by EMSA analysis (n=6, Figure 
7b,c).  In addition, consistent with a detrimental effect of increased NF-κB activity in aged 
myofibers on muscle regenerative potential, the cross-sectional area of regenerated myofibers 
was significantly greater in 2-year old MISR mice as compared to age-matched littermate 
controls (n=5, Figure 7d,e).  Aged MISR mice were not protected from age-related loss of 
satellite cells, which were similarly reduced in frequency when isolated from MISR animals or 
from littermate controls (n=5, Figure 7f). However, lifelong blockade of NF-kB activity in muscle 
fibers did ameliorate the reduction in satellite cell myogenic activity, measured in colony-forming 
assays of satellite cells isolated from aged MISR muscle (n=6, Figure 7g). No differences were 
noted in young MISR mice versus age-matched littermate controls with regard to skeletal 
muscle regeneration or colony formation (n=7, Figure 8a,b).  Thus, modulating inflammatory 
gene expression in mature muscle fibers yields a cell-non-autonomous effect on resident 
satellite cells, consistent with a “niche” effect of aging on satellite cell function. 
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Muscle regeneration is restored in MISR-SCIKK mice 
Next, I generated MISR-SCIKK mice by crossing MISR and SCIKK mice to test if 
dominant inhibition of NF-κB in myofibers alone is sufficient to restore the impaired muscle 
regeneration in SC-IKK muscle. As shown in Figure 9, MISR-SCIKK mice indeed showed 
improved muscle regeneration compared to SCIKK littermates as measured by the cross-
sectional area of regenerating myofibers 7 days after dry ice injury (n=5, Figure 9).   
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Sodium salicylate treatment improves myogenic function of satellite cells in aged 
mice and SC-IKK mice. 
Thus far, my data in two complementary transgenic mouse models demonstrates a non 
cell-autonomous inhibitory effect of increased NF-κB stimulated gene expression on satellite cell 
function. Additionally, my data from MISR animals suggests that restraining NF-κB activity 
throughout life may protect against some age-acquired defects in satellite cell activity and 
muscle regeneration (Figure 10). I also wondered whether acute inhibition of NF-κB signaling 
would also be effective in reversing age-related defects in muscle repair.  To test this possibility 
and evaluate the therapeutic potential of NF-κB inhibition for stimulating muscle repair in aged 
individuals, I attempted to rejuvenate aged muscle using sodium salicylate, a non-steroidal anti-
inflammatory drug previously reported to inhibit NF-κB signaling. As an active metabolite of 
aspirin, salicylic acid is known to suppress the activity of cyclooxygenase (COX), an enzyme 
that is responsible for the production of pro-inflammatory mediators such as the prostaglandins. 
Aspirin and sodium salicylate specifically inhibit IKKb/NF-κB axis in vitro and in vivo by reducing 
ATP binding in IKKb (Yin, 1998). Previous studies have demonstrated high-dose salicylate 
therapy to be safe in mice and humans and effective in reducing NF-κB mediated inflammation 
by inhibiting the kinase activity of IKKb (Kopp, 1994; Cai, 2004; Goldfine, 2010). Administration 
of high-dose salicylate also reduced circulating levels of C-reactive protein, nitric oxide, and 
sCD140L, which are regulated by NF-κB (Goldfine, 2010). The decreases in levels of circulating 
proteins and enzymatic products are consistent with inhibition of NF-kB and support it as a 
molecular target of high-dose salicylate. Moreover, systemic administration of sodium salicylate 
decreased muscle atrophy in MIKK mice caused by myofiber-restricted over-expression of IKKb 
(Cai, 2004).  However, what role, if any, sodium salicylate might play in modulating skeletal 
muscle regeneration has not been studied.  
 To test salicylate effects on aged muscle satellite cells and muscle regenerative activity,  
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aged mice (24 months of age) were placed on either high-dose sodium salicylate or control diet 
for a total of 6 to 8 weeks.  EMSAs performed on whole hind limb skeletal muscle demonstrated 
a 50 % decrease in NF-κB activity in salicylate-treated animals (n=9, Figure 11a,b).  Freshly 
isolated satellite cells from sodium salicylate treated aged mice similarly displayed evidence of 
reduced NF-κB signaling, indicated by a significant decrease in inflammatory gene expression 
(n=4-6, Figure 11c). Similar to results obtained in MISR mice, satellite cells collected from 
salicylate treated aged mice also showed no change in satellite cell frequency (n=8, Figure 11d 
, 12a,b) but did exhibit significant improvement in myogenic colony forming ability (n=8, Figure 
11e). Aged mice treated with sodium salicylate also displayed improved muscle regeneration on 
day 7 following injury in vivo (n=7, Figure 11f,g).  By day 14, there was a trend towards 
improved muscle regeneration (n=5, Figure 13a,b).  Young mice treated with sodium salicylate 
versus control feed showed no difference in skeletal muscle regeneration following injury, in 
satellite cell frequency, or in myogenic colony formation (n=5-7, Figure 14a,b, 15a,b).   
In young SC-IKK mice, systemic treatment with the NF-κB inhibitor sodium salicylate 
rescued the enhanced inflammatory gene expression in tamoxifen-treated SC-IKK satellite cells 
(Figure 15c), and ameliorated the regenerative defect (n=7, Figure 15d,e), confirming the 
involvement of heightened NF-κB activity in the observed phenotype. Administration of sodium 
salicylate did not affect satellite cell frequency or colony-formation of SC-IKK satellite cells (n=5, 
Figure 15a,b), which were not altered in comparison to age-matched WT controls. 
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Satellite cells with NF-κB activation exhibit increased DNA damage that is reversed by 
inhibition of NF-κB activity in myofibers. 
Next question I asked was about how NF-κB activation causes impairments in satellite 
cell function. NF-κB has been implicated in cellular senescence and oxidative damage, including 
DNA damage and protein damage through the generation of mitochondrial reactive oxygen 
species. As discussed above, stem cells persist throughout life in a largely quiescent state. As a 
result, stem cells in aged tissues experience long-term exposure to genotoxic assaults, from 
both endogenous and exogenous sources, and an apparent accumulation of DNA damage in 
aged stem cells has been noted in several studies. For example, aged HSCs and satellite cells 
show an increased number of nuclear foci that stain for the phosphorylated form of the variant 
histone H2A.X (gH2A.X), which serves as a marker of DNA double-strand breaks (Rossi, 2007; 
Rübe, 2011; Sinha, 2014; Rogakou, 1998). Accumulation of DNA damage in these stem cells 
can also be detected using single-cell gel electrophoresis assays, or comet assay (Sinha, 2014; 
Beerman, 2014). However, the level of DNA damage in stem cells must be interpreted with 
caution with regard to its role in aging because such damage can be repaired, or asymmetrically 
passed on to daughter cells, and may be involved in normal cellular process such as 
differentiation (Beerman, 2014; Larsen, 2010; Charville, 2011). 
Recently, our lab has shown that the high level of DNA damage in satellite cells of aged 
mice can be reversed by exposure of systemic factors in circulation of young mice (Sinha, 
2014). Also, different levels of DNA damage induced by irradiation exhibited negative correlation 
with satellite function, suggesting the relevance of DNA damage to muscle regeneration (Sinha 
2014). Based on these data, I examined DNA damage levels in satellite cells of injured and 
uninjured SC-IKK muscle. Comet assay on SC-IKK satellite cells showed a greater percentage 
of cells with highly damaged DNA than the fraction of damaged nuclei seen among WT satellite 
cells, and this difference was amplified when the muscles were injured (n=4, Figure 16a,b). 
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These data suggest that both cell-autonomous and non cell-autonomous NF-κB signaling might 
contribute to the accumulation of DNA damage in satellite cells. Satellite cells of older SC-IKK 
mice with prolonged NF-κB activation in satellite cells also showed higher DNA damage level 
compared to age-matched WT controls (n=4-6, Figure 16c). Importantly, life-long inhibition of 
NF-κB activity in myofibers (aged MISR mice) appeared to prevent the accumulation of DNA 
damage in aged satellite cells, with the fraction of satellite cells with highly damaged DNA 
approximately unchanged in aged MISR mice as compared to young controls (n=4, Figure 16d). 
These data suggest that inhibition of non cell-autonomous NF-κB signaling preserves the 
myogenic function of aged satellite cells in part by protecting them from DNA damage 
accumulation. The precise mechanisms by which NF-κB causes accumulation of DNA damage 
in satellite cells and how that accumulation leads to declining satellite function remains to be 
studied. 
 
Discussion 
 In summary, the data reported in this chapter suggest that chronic inflammation, mediated 
by NF-κB, retards the myogenic potential of satellite cells in aged muscle. Substantiating this 
observation, satellite cells from young mice with genetically induced high IKKb activity exhibit 
poor skeletal muscle regeneration, an effect that can be partly reversed with sodium salicylate 
treatment. However, although NF-κB target genes were activated in satellite cells in aged mice, 
and in mice harboring a satellite cell-specific IKKb transgene, these satellite cells exhibited no 
cell intrinsic defects in frequency or myogenic function.  Rather, defective satellite cell function 
in the context of induced NF-κB activity was revealed only when mature muscle fibers exhibited 
this heightened NF-κB signaling (either in aged mice or when SC-IKK nuclei were incorporated 
into regenerating myofibers during muscle repair).  These data are consistent with cell extrinsic 
regulation of satellite cell function in these contexts, a notion that is further supported by the  
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observation that aged MISR mice, which maintain dominant inhibition of NF-κB function in 
muscle fibers alone, are partially protected from age-dependent loss of satellite cell myogenic 
function. Improved muscle regeneration in MISR-SCIKK mice, with activation of NF-κB in 
satellite cell and inhibition of NF-κB in myofibers, also adds evidence to support the cell extrinsic 
regulation of satellite cell function by NF-κB signaling in muscle fibers. 
 The results reported here are consistent with prior studies demonstrating that NF-κB 
inhibition can slow muscle atrophy (Li, 2008) and can increase the cross sectional area of 
regenerating fibers following injury in a murine model of muscular dystrophy (Mourkioti, 2004).  
However, this study is the first to discriminate the impact of NF-κB elevation in skeletal muscle 
fibers versus satellite cells, and reveals a surprising non-autonomous regulation of satellite cell 
regenerative function by NF-κB driven gene expression in regenerating myofibers.   
 This study further demonstrates that systemic inhibition of NF-κB activity promotes more 
robust muscle regeneration in aged animals. Administration of high-dose sodium salicylate 
improves muscle regeneration and should be considered as a potential pharmacologic therapy. 
In addition, more specific inhibitors of IKKb might be useful to develop treatments for 
sarcopenia, since sodium salicylate itself has a wide ranges of other targets, and the high does 
of it required for IKKb inhibition are often not well tolerated due to dose-dependent and dose-
limiting side effects, such as tinnitus, headache and irritation in gastrointestinal tract. To date, 
only one other FDA approved drug, Losartan, has shown promise at a basic science level as a 
potential therapeutic agent (Burks, 2011). Further studies of this pathway will be helpful in 
revealing other potential targets for improving skeletal muscle regeneration in older age.   
 As for how satellite cell function is affected by extrinsic NF-κB signaling, this study 
suggests accumulation of DNA damage induced by activation of NF-κB. The mechanisms by 
which accumulation of DNA damage in aged stem cells may contribute to stem cell dysfunction 
are still being elucidated. Genotoxic lesions could cause stem cell senescence or apoptosis and 
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might directly affect gene regulation, leading to alterations in stem cell self-renewal and 
differentiation. Elevated levels of damaged DNA in aged stem cells could result from an 
accumulation of damage over time, an increase in the rate of damage, a decrease in the rate of 
repair in response to DNA damage, or a combination of these possibilities. Supporting a role for 
changes in the DNA damage response (DDR), aged human HSC show compromised capacity 
to repair experimentally introduced DNA damage, such as that produced by ionizing radiation 
(Rube, 2011). These observations suggest that DDR pathways, evolved to safeguard genomic 
integrity and maximize survival of the organism (Rossi, 2008; Ciccia, 2010; Fortini, 2013; 
Behrens, 2014), may show reduced activity in stem cells with age. Indeed, such changes have 
been observed in other aging cell types (Moskalev, 2013; Bernardes de Jesus, 2013). However, 
in muscle satellite cells, DDR protein levels did not alter with aging (Shinha, 2014).  Sinha et al 
rather pointed out the conserved necessity of strand break in stem cells for nuclear 
reprogramming to allow for cell differentiation (Larsen, 2010). Based on the up-regulation of 
muscle differentiation gene in aged satellite cells, it was suggested that aged satellite cell are 
arrested at an early stage of myogenic differentiation which induce DNA strand breaks without 
resolving them (Sinha, 2014). As previous observation implicated NF-kB in regulation of 
myogenic differentiation as an inhibitor of MyoD expression (Guttridge, 2000), it will be 
interesting to see if NF-kB activity is involved in arresting aged satellite cells in early stages of 
myogenic differentiation and inducing unresolved, differentiation-related DNA strand breaks.  !
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Chapter 3.  
Secretory Phospholipase A2 Functions as a Downstream Effector of  
NF-κB-mediated Chronic Inflammation in Aged Muscle. 
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Preface 
Secretion of phospholipase A2 (PLA2) is thought to induce inflammatory responses in 
neighboring cells, initiating or potentiating the local and systemic inflammatory processes such 
as sepsis and associated acute lung injury as well as inflammatory arthritides (Balsinde, 1999; 
Ohta, 2013). There are three broad classes within PLA2 superfamily: calcium-independent, 
secretory, and cytosolic PLA2; and each class is subdivided into isoenzyomes. The PLA2 
superfamily shares a common feature of catalyzing the hydrolysis of membrane phospholipids 
to generate lysophospholipids and free fatty acids including arachidonic acid. Arachidonic acid 
liberated by PLA2 is converted into prostaglandin H2 (PGH2) by catalytic activity of 
cyclooxgenase-1 (COX-1) and cyclooxgenase-2 (COX-2). Then by various terminal synthases, 
PGH2 is converted into biologically active prostanoids, including prostaglandins PGE2, PGI2, 
PGE2α, PGD2 and thromboxane A2.   
Aspirin and most of the widely known non-steroidal, anti-inflammatory drugs currently in 
use inhibit cyclooxygenases, thereby suppressing the synthesis of prostaglandins (Vane, 1998). 
As discussed in Chapter 2, treatment of a non-steroidal, anti-inflammatory drug, sodium 
salicylate, was shown to improve muscle regeneration by enhancing satellite cell function in 
aged mice, providing an intriguing insight into possible roles of PLA2 and prostaglandins in 
aging of the muscle stem cell niche (Figure 17). Although the role of secretory PLA2 in skeletal 
muscle still remains unclear, accumulating evidence suggests that prostaglandins and 
leukotrienes, another type of metabolite of arachidonic acid, are involved in causing muscular 
pain and inflammation, and also in myogenesis and the repair of muscles (Korotkova, 2014). 
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A gene array analysis of muscles collected from young WT, aged WT, and aged MISR 
mice that we performed in an effort to identify possible secretory factors that may be involved in 
the NF-κB-regulated influence of the aged muscle niche on satellite cells, revealed pla2g5 and 
pla2g7 (genes that encode PLA2 group V and VII respectively), as promising candidate 
mediators of this effect (Supplemental figure 3, 4, 5, Supplemental table 1). Validation of our 
gene array results by qRT-PCR analysis confirmed a number of candidate genes that were up-
regulated in aged WT but down-regulated in aged MISR, young WT and young MISR muscle 
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(n=5-6, Supplemental figure 4). To test if any of the validated genes have a potential role in 
muscle regeneration in aged mice, I divided them into two groups and performed pooled 
screens by electroporating cocktails of siRNAs for each group of genes into aged TA muscles. 
At 24 hours post electroporation, muscles underwent cryoinjury and were harvested at day 7 
after injury. Knockdown of one group of genes (kcnab1, pla2g5, pla2g7, and cadm1) showed a 
trend towards increased cross sectional area of regenerating myofibers in the cryoinjured TA 
muscle of aged mice (Supplemental figure 5), driving our further interest in sPLA2s and their 
role in the regenerative biology of aged muscle. 
 
Results 
Knockdown of pla2g5 improves muscle regeneration in aged mice. 
Pla2g5 encodes PLA2 group V, a member of the calcium-dependent, secretory PLA2 
family. Transcription factor binding site analysis by Genomatix (Supplemental table 1) and 
ChIPseq data provided by the genome browser of The Encyclopedia of DNA Elements 
(ENCODE) showed NF-κB binding site in the promoter region of pla2g5 gene (data not shown), 
corroborating the regulation of pla2g5 by NF-κB. High affinity binding of NF-κB to the promoter 
region of pla2g5 was also witnessed by protein-DNA mobility shift assays in a recent study 
focused on pulmonary inflammation (Sun, X., 2014). 
 Expression of pla2g5 is increased in aged skeletal muscle as compared to young WT, 
young MISR or aged MISR mice (n=6, Figure 18a).  Furthermore, inhibition of pla2g5 
expression by in vivo electroporation of pla2g5 siRNA was sufficient to restore skeletal muscle 
regeneration in aged mice (n=5, Figure 18b,c), suggesting that NF-κB inhibits muscle 
regeneration in part by up-regulation of pla2g5 within skeletal muscle fibers.  
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 The level of gene knockdown in aged muscles electroporated with pla2g5 siRNA was 
measured at the time of tissue harvest and was 51.9% on average (S.D±24.1%, n=14) (Figure 
18d). This knockdown level was comparable to the difference in the level of pla2g5 mRNA in 
aged WT versus aged MISR or young WT, as shown in Figure 17a. For controls, contralateral 
TA muscle was electroporated with scrambled siRNA designed to have no specificity to any 
mammalian genes but having a similar GC content as pla2g5 siRNA. mCherry fluorescent 
protein-expressing plasmid was co-electroporated with the siRNA as a reporter of fiber 
transduction, allowing for estimation of the efficiency of electroporation by visualizing mCherry+ 
myofibers in each sample (Supplemental figure 6).  
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 I also performed a linear regression analysis between knockdown level of pla2g5 
expression and increase in average size of regenerating myofibers, to evaluate whether 
knockdown of pla2g5 improves muscle regeneration in a dose-dependent manner. A trend of 
increasing regenerating myofiber size with higher knockdown level was observed, although it 
did not reach statistical significance (n=14, Supplemental figure 7). Thus, PLA2G5 may not 
necessarily behave in a dose-dependent manner in muscle regeneration, possibly because 
there is a threshold level of PLA2G5 required for its pro-inflammatory role that affects muscle 
regeneration in aged mice. Also, it is possible that translational or post-translational regulation of 
pla2g5 mRNA or protein also impacts the outcome of pla2g5 knockdown in muscle 
regeneration.   
 
Knockdown of pla2g5 restores NF-κB-mediated impairment of muscle regeneration. 
To test whether the beneficial effect of knocking-down pla2g5 in muscle regeneration is specific 
for NF-κB-induced muscle inflammation, tamoxifen-induced SC-IKK mice (3-months old) were 
treated with pla2g5 siRNA electroporation in muscle and analyzed for their regenerative 
capacity under the same conditions under which old mice were examined (see above). SC-IKK 
mice also showed improved muscle regeneration when electroporated with pla2g5 siRNA prior 
to cryoinjury (n=5, Figure 19a,b), with an average 64.3% (S.D±27.3) knockdown of pla2g5 
expression (Figure 19c). Such improvement in muscle regeneration was not present in age-
matched young WT controls in which pla2g5 was knocked down (Figure 20). 
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Discussion 
This study establishes PLA2G5 as a novel downstream effector of NF-κB in regulating 
muscle repair in response to injury, and demonstrates that inhibition of this target in muscle 
fibers alone is sufficient to reverse age-related and NF-κB-mediated deficits in satellite cell 
activity and function. Further studies are required to understand at a molecular and biochemical 
level how PLA2G5 alters satellite cell physiology to influence muscle regeneration.  
PLA2G5 catalyzes the hydrolysis of membrane phospholipids to generate 
lysophospholipids and free fatty acids including arachidonic acid. It preferentially hydrolyzes 
linoleoyl-containing phosphatidylcholine substrates. Secretion of this enzyme is thought to 
induce inflammatory responses in neighboring cells. This enzyme, once secreted, associates 
with the outer surface of the cells and then releases arachidonic acid, which can be captured by 
surrounding cells to produce eicosanoids, including the prostaglandins and its analogs, 
thromboxanes, lipoxins, and leukotrienes, (Balboa, 1996; Balsinde, 1999). Based on these 
previous observations, I postulate that PLA2G5 secreted by myofibers into the interstitial space 
in muscle tissue react with membrane phospholipids of neighboring myofibers, and many other 
cell types that are present in muscle tissue, such as fibroblasts, endothelial cells and smooth 
muscle cells. Several studies have convincingly demonstrated that skeletal myofibers can 
produce prostaglandins. For example, isolated primary chick myoblasts and myotubes are able 
to produce PGE and PGF in vitro from endogenous arachidonic acid, and this process is 
enhanced in the presence of exogenous arachidonic acid (McElligott, 1988). Also, human and 
mouse myoblasts produce PGE2 and PGF2α (Zalin, 1987; Otis, 2005), and primary mouse 
myoblasts express PGI synthase and the PGI2 receptor and generate PGI2 (Bondesen, 2007).  
Activation of PLA2 is a rate-limiting step in the biosynthesis of prostaglandins (Cirino, 
1998). Although little is known about PLA2 expressed and secreted by skeletal muscle tissue, a 
role for different types of prostaglandins in myoblasts has been well documented. In studies 
! 47!
published to date, prostaglandins have been reported to influence multiple steps of myogenesis, 
including proliferation (Zalin, 1987; Otis, 2005), differentiation (Zalin, 1987), migration 
(Bondesen, 2007), fusion (Bondesen, 2007), and survival of myoblasts (Jansen, 2008).  
On the other hand, prostaglandins are powerful mediators of inflammation and pain, and 
are involved in cytokine production and nitric oxide synthase expression, increases in 
vasodilation and vascular permeability, and chemotaxis of inflammatory cells. PGE2, in 
particular, seems to be a particularly potent mediator of muscular pain and inflammation, and 
has been suggested as a potential mediator of skeletal muscle wasting (Tegeder, 2002; 
Hedenberg-Agnusson, 2001). However, controversy exists regarding the effect of PGE2 on 
protein breakdown in isolated skeletal muscles (Rodemann, 1982a; Rodemann, 1982b; Barnett, 
1987; Hasselgren, 1990). A number of animal models of diseases have linked excessive 
production of prostaglandins to muscle wasting (Rieu, 2009; Granado, 2007; Strelkov, 1989; 
McCarthy, 2004). In a rat model of arthritis, muscle wasting was associated with the induction of 
specific E3 ubiquitin ligating enzymes, such as muscle atrophy F-box and muscle specific RING 
finger protein 1 (MuRF1), which are markers of muscle atrophy (Strelkov, 1989). PGE2 directly 
induced the expression of these mediators of muscle loss in human skeletal muscle ex vivo, 
thereby confirming its role in muscle wasting (Standley, 2013). Whether the PGE2 biosynthetic 
pathway is up-regulated in the muscles of patients with chronic inflammatory diseases is, 
however, unknown. Regardless, PGE2 appears to be a promising candidate to study as a 
mediator of PL2G5-driven decline in muscle function. As prostaglandins function as both 
autocrine and paracrine signal, it is possible that prostaglandins produced in myofibers further 
propagate the pro-inflammatory effect of PLA2G5 to neighboring cells in muscle tissue. 
In addition, the role of this secreted phospholipase in age-related deterioration of muscle 
regeneration might lead to an interesting insight into a previously unappreciated role of lipid 
mediators in muscle function. A recent study by Sato et al reported that adipocyte-induced 
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PLA2G5 drives M2 polarization of macrophages in adipose tissue of obese mice (Sato et al, 
2014). As M1 and M2 macrophages have distinct roles at difference stages of muscle 
regeneration, studies to examine the resident M1 and M2 populations in muscles of young and 
aged mice, and mice with different modulation of NF-κB or pla2g5 activity, might provide a new 
aspect in the role of muscle-derived PLA2G5 in aging skeletal muscle.  !
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Chapter 4. 
IL-6 restricts satellite cell function 
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Preface 
Interleukin-6 (IL-6) is a pleiotrophic cytokine that plays a key role in inflammation by 
modulating a variety of physiological responses and activating genes associated with cellular 
proliferation, differentiation, and apoptosis (Kishimoto, 2006; Jones, 2005). IL-6 signals through 
IL-6 receptor and plasma membrane receptor complex, which contains the common signal 
transducing receptor chain, glycoprotein130. Activation of gp130 leads to the activation of JAK 
tyrosine kinases, induction of tyrosine phosphorylation and recruitment of signal transducer and 
activator of transcription 3 (STAT3). 
IL-6 is produced by a variety of cell types, including monocytes, fibroblasts, vascular 
endothelial cells, and skeletal muscle fibers (Akira,1993, Jonsdottir, 2000).  As a “myokine”, a 
cytokine produced from muscle fibers, serum IL-6 levels acutely increase during muscle 
contraction (Febbraio, 2002a). IL-6 gene expression also increases during functional overload 
and recovery from disuse atrophy (Whites, 2009; Washington, 2010), indicating IL-6 as a 
muscle mitogen that can activate cell proliferation in skeletal muscle (Cantini, 1995). On the 
other hand, recent studies showed that IL-6-activated STAT3 signaling promotes myogenic 
progression by regulating MyoD in satellite cells (Tierney, 2014). 
Increased levels of IL-6 have been implicated in numerous pathophysiological conditions, 
such as cancer cachexia, sepsis, insulin resistance, and acidosis where muscle atrophy is 
evident (Strassmann, 1992; Baltgalvis, 2008a; Kern, 2001), to induce skeletal muscle protein 
breakdown (Goodman, 1994). Additionally, a striking correlation exists between age-related 
muscle defects and chronic inflammation in elderly patients, as measured by high levels of IL-6 
(Schaap, 2006). Population studies have associated higher circulating IL-6 with physical frailty 
and disability, including sarcopenia (Maggio, 2006). In fact, localized chronic IL-6 exposure has 
been found to cause arrested skeletal muscle growth and induces atrophy in rats (Bodell, 2009; 
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Haddad, 2004). Also, transgenic mice over-expressing IL-6 at high levels in all tissues and in 
circulation also exhibit muscle atrophy (Tsujinaka, 1995). Based on these observations, I 
hypothesized that circulating IL-6 is an “aging factor” whose level gradually increases during 
aging, causing accumulation of damage in cells and degeneration of tissue. The IL-6 gene has a 
direct binding site for NF-κB, which I found could induce deterioration of satellite cell function 
and muscle regeneration in aged muscle by mediating chronic inflammatory signaling in muscle 
fibers (Chapter 2). Moreover, IL-6 was one of the most highly up-regulated target genes of NF-
κB expressed by aged in comparison to young satellite cells (Figure 3). These data suggest the 
potential involvement of IL-6 in regulating satellite cell-mediated muscle regeneration and 
maintenance in an age-dependent manner.   
 
Results 
Serum level of IL-6 is higher in old mice compared to young mice, but IL6 mRNA is not 
induced in skeletal muscle.  
First, I compared IL-6 expression in young and aged mice at multiple levels. Serum IL-6 
level measured by ELISA was significantly higher in aged mice (n=6), verifying a previous study 
in humans that reported a clear increase in serum IL-6 with advancing age (Young, 1999; 
Ershler, 1993). Whole muscle IL-6 mRNA levels were higher in aged mice than in young mice, 
although the difference did not reach statistical significance (n=20, p-value <0.058; Figure 21). 
Multiple human studies also failed to detect changes in IL-6 mRNA expression in the whole 
skeletal muscle of elderly humans compared to younger adult muscle (Hamada, 2005; Trenerry 
M.K., 2008; Przybyla. B., 2006), implying that muscle is not a major source of age-dependent 
increases in circulating IL-6. In the case of satellite cells, however, IL-6 mRNA level increased 
with age as shown in chapter 2 (Figure 3e). In addition, a gene array analysis performed 
previously in the Wagers lab on satellite cells isolated from young, mid-aged, and  
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aged mice indicated IL-6 as one of the top candidate genes whose mRNA level increases the 
most with age (Supplemental figure 8).  This led us to speculate that up-regulation of IL-6 
mRNA in satellite cells, together with the systemic elevation of IL-6 protein, might be involved in 
age-dependent functional decline of muscle regenerative potential. 
 
Depletion of IL-6 improves satellite cell survival. 
Based on the results in Figure 20 and on previous studies interrogating the possible role 
of systemic factors in aging of muscle stem cell (Conboy, 2005), IL-6 knockout (KO) mice with 
neomoycin resistance cassette insertion in the first coding exon, exon 2, of the IL-6 gene were 
utilized to study the possible role of IL-6 in aging muscle stem cells (Kopf, 1994). Satellite cells 
isolated from IL-6 KO mice showed restrictive effects of IL-6 on the survival of satellite cells in 
vitro. IL-6 KO satellite cells exhibited greater myogenic colony formation efficiency both in young 
(n=20) and old age (n=8), compared to age-matched WT controls (Figure 22a). Moreover, this 
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improved myogenic colony formation was reversed by treating IL-6 KO satellite cells with 
recombinant IL-6 in culture (n=5, Figure 22b). 
To further test the myogenic function of IL-6 in satellite cells in vivo, IL-6 KO satellite 
cells were transplanted into pre-injured IL-6 KO or WT recipient muscles and evaluated for 
engraftment after 4 weeks. For this experiment, IL-6 KO mice were crossed to GFP transgenic 
mice, which express green fluorescent protein (GFP) under control of the ubiquitous β-actin 
promoter, in order to visualize engrafted myofibers by epifluorescence (Figure 22c,d). GFP+ IL-6 
KO satellite cells engrafted better than GFP+ WT satellite cells when transplanted into IL-6 KO 
recipients as measured by the number of engrafted myofibers (n=5-8, Figure 22d,e). This effect 
was not observed in WT recipients, possibly because IL-6 KO satellite cells become exposed to 
IL-6 when transplanted into WT muscle. Interestingly, the average size of myofibers engrafted 
by IL-6 KO satellite cells tended to be greater than WT satellite cells regardless of the genotype 
of the recipient, suggesting that the growth of engrafted myofibers depends more on intrinsic, 
rather than extrinsic, expression of IL-6 (n=5-8, Figure 22f). It is also important to note that the 
higher engraftment efficiency of IL-6 KO satellite cells in IL-6 KO recipient could be due to 
ameliorated host inflammatory response in the complete absence of functional IL-6, which inflict 
less damage on the transplanted satellite cells than the WT environment, ultimately allowing for 
greater satellite cell survival and producing more engrafted myofibers. It has previously been 
demonstrated that myoblast transplantation into wild-type animals leads to cell death for 95-99% 
of cells within days of transplant (Tremblay, 1997). The authors of this study attributed acute 
myoblast death to an innate immune/inflammatory response mounted against transferred cells 
by the host. 
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IL-6 negatively affects muscle regeneration and strength in young mice. 
IL-6 KO mice were examined for their regenerative capacity. Young IL-6 KO mice 
showed greater cross sectional area of regenerating myofibers than young WT mice at day 14 
after cryoinjury (n=5-8; Figure 23c). However, regenerating myofibers of IL-6 KO mice assessed 
at earlier time points after cryoinjury, day 5 and day 7, were not distinguishable from those of 
WT mice (n=5-8; Figure 23a,b). Also, the histology of muscle tissues in the resting state (without 
injury) was not different between IL-6 KO and WT mice (data not shown). This result points to 
potentially pleiotropic effects of IL-6 in muscle healing. That is, it is possible that damage-
induced increases in IL-6 expression, which have been shown to be necessary at the onset of 
injury for successful myoblast proliferation and differentiation, may act later to inhibit myoblast 
fusion into multinucleated myofibers (Zhang et al., 2013).  At earlier time points after injury (days 
5 or 7), other inflammatory factors, such as TNF-α and members of the interleukin family, are 
likely able to compensate for the role of IL-6, resulting in similar level of muscle regeneration in 
IL-6 KO and WT mice at day 5 and 7 after injury. In the later stages of muscle regeneration, on 
the other hand, IL-6 might change its role, which might not be replaced by other inflammatory 
factors. Such a model would explain the different results at different time points after the dry ice 
injury experiment on IL-6 KO and WT mice.  
Next, young IL-6 KO and WT mice were subjected to prolonged IL-6 exposure in order to 
mimic the chronic inflammatory state of aged mice. Mice were injected with 300 pg/kg of human 
recombinant IL-6 (or PBS as a control) twice a day intraperitoneally for three weeks. The 
dosage of injection was determined to produce circulating IL-6 levels comparable to those of 
aged mice (Figure 21a) or other mouse models for metabolic diseases (Dal Kim, 2013). The 
amount of injected IL-6 was much lower than serum IL-6 levels observed in mice in acute 
inflammatory phase or with sepsis (Hua Huang, 2009; Casey, 1993). After three weeks of IL-6  
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injection, mice were cryoinjured in the TA muscle and the muscles were harvested at day 14 
after injury for analysis. However, daily injection of IL-6 did not cause any change in muscle 
regeneration in IL-6 KO or WT mice (n=3; Supplemental figure 9a,b). A trend of decreased 
colony formation efficiency of satellite cells isolated from IL-6 KO mice injected with IL-6 was 
observed, although it was not statistically significant (n=7; Supplemental figure 9c).  One point 
of concern is that the half-life of IL-6 is less than 6 hours in serum when not bound to soluble IL-
6 receptors. It is possible that injected IL-6 might be degraded much faster than expected, 
providing only a brief boost in serum IL-6. At the same time, the 3-week period of IL-6 exposure 
might not have been enough to mimic the muscle niche of aged mice.  
This study was repeated using electroporation of an IL-6-overexpressing plasmid into 
the mouse TA muscle (as previously described by Baltgalvis et al. (2008)).  Baltgalvis et al. 
showed that the electroporated quadricep continuously secretes IL-6 into the bloodstream, 
increasing systemic levels of IL-6.  This is therefore a more realistic way to simulate chronic IL-6 
elevation in young mice. TA muscles were cryoinjured 3 weeks after electroporation of IL-6-
expressing or empty vector plasmid (Manderson et al., 2007).  mRNA levels of IL-6 in the 
muscles electroporated with IL-6 plasmid measured by qPCR at harvest showed 437 fold 
increases, as compared to IL-6 level in muscles with electroporation of empty vector (n=7, 
p=0.007). Muscles with IL-6 overexpression showed drastic decrease in the size of regenerating 
myofibers starting at day 7 after injury compared to control muscles electroporated with empty 
vector under the same condition (n=6, Figure 24a). The contralateral of TA muscles with IL-6 
plasmid electroporation also showed reduced muscle regeneration, possibly due increased 
circulation of IL-6 produced by the electroporated muscle (n=7, Figure 24b). Regenerating 
myofiber size was smallest in the IL-6 overexpressing muscles, suggesting that higher levels of 
IL-6 in the microenvironment causes worse muscle regeneration (Figure 24b). 
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Based upon these experiments, I conclude that IL-6 is restrictive for the regenerative 
ability of skeletal muscle.  This effect of IL-6 is likely mediated through extracellular IL-6, 
potentially in combination with IL-6 expression in satellite cells, which increases with age and 
reduces the myogenic potential of satellite cells.  In addition, IL-6 seems to have a negative 
impact on whole muscle strength and endurance, which was quantified by modifying an existing 
wire hang protocol obtained from the Wellstone Muscular Dystrophy Center (Washington, DC).  
Mice were allowed to hang upside-down from wire bars at a height of 35cm, and latency-to-fall 
was measured based on three timed attempts per trial (Figure 25a). Three trials in the period of 
a week were performed on each set of mice. Young IL-6 KO (n=6) mice exhibited significantly 
greater muscular endurance in the wire hang test compared to either young (n=8) or old (n=7) 
WT mice, as measured by the amount of time hung on (Figure 25b). 
 
 
 
Depletion of IL-6 is not sufficient to reverse muscle aging. 
Based on the results described above for young mice, I hypothesized that life-long 
depletion of functional IL-6 could be helpful for delaying muscle aging. To test this hypothesis 
aged IL-6 KO mice were examined for the myogenic potential of satellite cells and muscle 
regeneration. Colony formation efficiency of satellite cells was significantly higher in aged IL-6 
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KO mice than in aged WT mice, and almost comparable to young WT, as shown in Figure 22a. 
However, aged IL-6 KO mice failed to show preservation of muscle regeneration (Figure 26). 
Size distribution of regenerating myofibers in aged IL-6 KO mice showed a higher frequency of 
smaller myofibers after cryoinjury compared to littermate controls. Although this trend did not 
reach statistical significance, it implies that IL-6 is required, to some extent, for aged muscle to 
recover from injury. Though unexpected, the reduced regenerative ability of aged IL-6 KO mice, 
as compared to age-matched controls, may in fact be caused by the fact that IL-6 KO mice are 
notably obese when aged. In fact, it was reported that by 9 months of age IL-6 KO mice become 
obese and diabetic due to reduced energy expenditure (Wallenius, 2010). By 24 months of age, 
IL-6 KO mice weighed 37% more than age-matched WT mice (n=6), whereas young IL-6 KO 
and WT mice had no difference in weight (n=10, Figure 27). Since the obesity of mice gives rise 
to a slew of deleterious effects, ranging from liver inflammation to an impaired immune 
response, the beneficial effect of IL-6 depletion observed in young mice might not have been 
recapitulated in aged mice (Matthews, 2010). It has been shown that maturation of regenerating 
myofibers is suppressed in mice fed with high fat diet for 8 months (Hu, 2010). I also witnessed 
that 12 weeks of high fat diet treatment in mice beginning at 2-months of age is enough to 
impair muscle regeneration in young mice (n=4, Figure 28b,c). Interestingly, however, young IL-
6 KO fed with high fat diet were protected from the obesity-associated decline in muscle 
regeneration (Figure 28a,c). Based on these data, I conclude that IL-6 plays a restrictive role in 
muscle regeneration by negatively affecting satellite cell survival and myofiber growth in young, 
relatively healthy mice. However, due to the multifactorial roles of IL-6 in many types of tissue, 
the accumulated effects global deletion of IL-6 results in obesity and associated metabolic 
complications over time, which ultimately disturb muscle maintenance through IL-6-independent 
pathways.  
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Regulation of IL-6 expression in muscle after injury is altered in aged mice.  
In parallel, I also asked if IL-6 is regulated differently in young and old mice during 
muscle repair. I examined changes in IL-6 levels in muscles of young and old WT mice after two 
forms of insult to muscle: cardiotoxin injury and acute exercise. It is well known that the immune 
response to injury involves inflammatory factors, produced by monocytes and macrophages that 
are recruited to sites of damage. For direct muscle injury, cardiotoxin was injected into the TA, 2 
and 5 days prior to harvest.  Both injured and uninjured TAs of young (n=6) and aged (n=4) 
mice were collected for qPCR analysis, and data are expressed as a ratio between injured and 
uninjured relative expression of IL-6, in order to see if the injury-induced IL-6 expression is 
altered with aging (Figure 29a,b).  I found that at 2 days after cardiotoxin injury, young and aged 
mice had approximately 120% and 50% increase in IL-6 expression relative to uninjured 
controls respectively. At 5 days after injury, aged mice still showed increase in IL-6 expression 
about 30% whereas young mice showed decreased IL-6 expression relative to uninjured 
controls. It is notable that effective muscle injury repair requires a tightly controlled inflammatory 
response, with both inflammatory and anti-inflammatory cytokines necessary to produce the 
resulting beneficial effect. Proinflammatory monocytes and neutrophils infiltrate into injured 
areas and differentiate into M1-type macrophage shortly after damage to clear the damage and 
release a number of cytokines/chemokines, including TNF-α, IL-1β, IL-6, and MCP-1 (Kharraz, 
2013). In the later stages of regeneration, M2 polarization of macrophages reduces the levels of 
TNF-α, IL-6, and MCP-1, and promotes myoblast differentiation and fusion (Kharraz, 2013). It is 
therefore likely that the prolonged activation of IL-6 detected in aged, cardiotoxin-injured skeletal 
muscle might prevent transition to an adequate anti-inflammatory response after muscle injury.  
To test inflammatory response after another form of muscle damage, young and old 
mice were subjected to exercise. Previous studies have found that contracting skeletal muscle 
responds to exercise by synthesizing and releasing IL-6 into the plasma (Fischer, 2006; 
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Febbraio, 2002b). Whole skeletal muscle was immediately harvested after one hour of uphill 
treadmill running and analyzed for expression of IL-6. Although the difference of means 
between whole muscle IL-6 transcription in resting and exercise states failed to reach statistical 
significance, both young and old mice tend to show a similar increase in average IL-6 
expression after exercise (n=7, Figure 29c). Since not all mice reached exhaustion after one 
hour of running, it is possible that the rigorous activity in the exercise protocol was not adequate 
to cause proper inflammatory response. The duration of exercise or speed of the treadmill need 
to be increased to further study the regulation of IL-6 in young and aged mice during/after 
exercise. 
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Discussion 
In summary, IL-6 has negative impact on muscle regeneration as shown by increased 
survival of IL-6 KO satellite cells in culture and in transplants, and greater myofiber growth after 
injury in young IL-6 KO mice. Satellite cells isolated from aged IL-6 KO mice showed further 
improvement in myogenic function of satellite cells in culture, but global deletion of IL-6 resulted 
ultimately in obesity and several associated metabolic diseases as mice age, causing declining 
muscle regenerative potential after injury as a secondary effect of obesity. Indeed, tocilizumab, 
the first IL-6 receptor-inhibiting monoclonal antibody approved recently for the treatment of 
rheumatoid arthritis and other inflammatory disorders, was reported to have side effects of 
weight gain and hyperlipidaemia, as reviewed by Febbraio et al. (Febbraio, 2010). This 
observation has been used to demonstrate the role of IL-6 in glucose homeostasis. Hence, 
while IL-6 is clearly pro-inflammatory in a range of diseases including sarcopenia, it is important 
to note that completely blocking IL-6 signalling can result in weight gain and hyperlipidaemia. 
The effect of hyperlipidemia on skeletal muscle mass and the interaction between adipose 
tissue stores and skeletal muscle size remain largely unknown. Despite the side effect of 
hyperlipidemia, the fact that transplanted IL-6 KO satellite cells show greater engraftment 
efficiency and greater myofiber size could suggests the possible utility of temporary inhibition of 
IL-6, perhaps through the use of IL-6-neutralizing antibodies, for increasing transplant efficiency 
in experimental, and perhaps clinical, applications.  
Further study is required to understand how IL-6 affects the survival and/or proliferation 
of satellite cell in culture as shown in colony formation assay in figure 22a. It is possible that pro-
apoptotic pathways or cell cycle regulation are altered in IL-6 KO satellite cells, resulting in 
higher cell survival and an increased colony formation rate in culture. Aged satellite cells were 
recently reported to switch to irreversible senescence from reversible quiescence (Sousa-Victor, 
2014) and exhibit increased rate of apoptosis with up-regulation of cell death genes (Fulle, 
! 66!
2013), providing insight into the reduced myogenic colony forming function of aged satellite cell 
and the potential role of IL-6 in satellite cell function.  
A recent study showed that IL-6-activated STAT3 signaling hinders satellite cell 
expansion during muscle repair by promoting myogenic lineage progression and asymmetric 
division of satellite cells, suggesting a causal role of IL-6 in the development of sarcopenia 
(Tierney, 2014). STAT signaling was also reported to be up-regulated in aged satellite cell, and 
genetic knockdown and pharmacological inhibition of Janus kinase (JAK) 2 and STAT3 
expression in satellite cells stimulated symmetric cell division in culture and enhanced their 
ability to repopulate the satellite cell niche after transplantation into regenerating muscle (Price, 
2014). In addition, the levels of STAT3 are elevated with muscle wasting as a downstream 
effector of IL-6 (Zhang, 2013), and STAT3 has been implicated in the regulation of self-renewal 
and stem cell fate in several tissues (Kiger, 2001). These results match in part with the trend of 
improved muscle regeneration in young IL-6 KO mice at day 14 after injury and greater 
engraftment efficiency of IL-6 KO satellite cell than WT satellite cells (Figure 22c,d,e, 23c). 
However, IL-6 KO and WT satellite cells used in this study did not show a significant difference 
in the level or timing of proliferation or differentiation in culture (Supplemental figure 10). It is 
possible that WT satellite cells isolated in culture do not produce sufficient amount of IL-6 to 
activate STAT3 signaling to the level to have an impact on the proliferation and differentiation of 
WT satellite cells. Assessing the levels of STAT3 signaling in IL-6 KO and WT satellite cells in 
culture will be helpful to explain how proliferation and differentiation of IL-6 KO satellite cell 
remain unaffected as compared to those of WT satellite cells. 
Greater regenerating myofiber size in young IL-6 KO mice corroborates the catabolic 
role of IL-6 in muscle. As previously mentioned, IL-6 has been indicated as a potent stimulator 
of muscle proteolysis in many diseases and conditions associated with muscle atrophy. More 
interestingly, a recent paper reported induction of IL-6 and MuRF-1 by PGE2 in human skeletal 
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muscle (Standley, 2013), providing another interesting connection between muscle mass 
regulation and limpid metabolism that was briefly discussed in Chapter 3. Lastly, studying the 
regulation of proteolytic activity of IL-6 in satellite cells might help further understanding of the 
mechanism(s) underlying age-dependent functional decline of satellite cells. 
 !
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Chapter 5. 
Inhibition of NF-κB activity by up-regulation of HSP72 is not sufficient  
to reverse muscle aging 
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Preface 
Muscle wasting, or atrophy, describes a progressive loss of muscle mass that occurs as 
a consequence of denervation, injury, and joint immobilization (Tawa, 1994; Mitch, 1996). 
Frequently observed in patients of muscular dystrophies as well as cancer, AIDS and other 
systemic diseases including sarcopenia, muscle atrophy primarily results from accelerated 
protein degradation in affected muscle cells (Tawa,1997). Protein degradation can be achieved 
in two ways—autophagy-lysosome pathway, or ubiquitin-proteasome pathway. Autophagy-
lysosome pathway is usually non-selective and involves a number of proteases, whereas the 
ubiquitin-proteasome pathway selectively targets proteins for ubiquitination, which is recognized 
by ubiquitin receptors at the proteasomes (Dikic, 2009). Hyper-activation of the ubiquitin-
proteasome pathway has been implicated in the degradation of intracellular skeletal muscle 
proteins (Tisdale, 2009).  Interestingly, TNF-α-induced NF-κB activation increases ubiquitin-
conjugating activity and up-regulates the ubiquitin-conjugating E2 enzyme, UbcH2 (Li, 2003), 
and inhibition of NF-κB protects against TNF-α-induced protein degradation in cultured muscle 
cells (Li, 2000). Expression of the E3 ligase MuRF1, a mediator of muscle atrophy, was 
increased in mice with muscle-specific activation of NF-κB activity (Cai, 2004), and blockade of 
the ATP-dependent ubiquitin-proteasome pathway with the inhibitor, MG132, inhibited NF-κB 
activity (Ortiz-Lazareno, 2008). Moreover, it is evident that IL-6 is involved in cancer cachexia, 
sepsis and acidosis (Bodell, 2009; Strassmann, 1992; Schaap, 2006), and induces skeletal 
muscle protein breakdown (Goodman, 1994). Based on results in previous chapters presenting 
the detrimental role of elevated NF-κB and IL-6 activity in muscle, I postulated that age-
associated chronic inflammation and accelerated proteolysis in muscle tissue might be closely 
related.  
Regulation of cellular processes responsible for protein quality control is known 
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collectively as protein homeostasis, or “proteostasis” (Bucciantini, 2002; Balch, 2008; Powers, 
2009). A proper balance between synthesis, maturation, and degradation of cellular proteins is 
mandatory for maintaining proteostasis, which is essential for most cellular functions, including 
replication of genetic material, catalysis of metabolic reactions, maintenance of cellular 
architecture, signaling and immune responses (Balch, 2008; Powers., 2009). As regards stem 
cell function, proteostasis has been implicated as an important determinant for maintaining the 
stem cell identity and function of human embryonic stem cells and hematopoietic stem cells 
(HSCs) (Vilchez, 2012; Warr, 2013; Mortensen, 2011).  
Proteostasis is regulated by a complex protein network that monitors the concentration, 
subcellular location and folding of proteins and includes molecular chaperones and folding 
enzymes, as well as pathways that drive protein degradation when needed, through the 
proteasome, lysosome and autophagy pathways (Balch, 2008; Powers, 2009; Taylor, 2011). 
Defects in proteostasis commonly lead to aberrant folding, toxic aggregation and accumulation 
of damaged proteins, which can in turn cause cellular damage and tissue dysfunction 
(Bucciantini, 2002). Indeed, age is one of the main risk factors for most diseases associated 
with protein misfolding, including neurodegenerative diseases such as Alzheimer’s disease, 
Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis (Moreno-Gonzalez, 
2011). This association suggests that aged cells may be more prone to form and accumulate 
misfolded protein aggregates, which might lead to hyper-activation of proteolytic pathways 
(Taylor, 2011; Morimoto, 2009).  
 Recent studies have reported age-dependent deficits in the activities of both the 
autophagy-lysosomal and the ubiquitin-proteasome systems, the principal proteolytic systems 
implicated in protein quality control (Rubinsztein, 2011; Tomaru, 2012). Yet other studies have 
challenged this view, showing instead that autophagic potential or proteasome activity remains 
intact in aged cells, and attributing age-related disruptions in proteostasis mainly to increasing 
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damage caused by metabolic stress that overwhelms the protective capacity of proteolytic 
systems (Warr, 2013; Cook, 2009; Altun, 2009). In support of the latter view, it has been 
suggested that the age-related decline in proteostasis and specifically the inability to up-regulate 
chaperones in response to conformational stresses would trigger disease manifestation and, in 
turn, accelerate proteostasis collapse (Hartl, 2011). It has been known that substrate recognition 
and processing in the ubiquitin–proteasome system require a close cooperation with molecular 
chaperones. Notably, the overexpression of members of the heat shock protein (HSP) system 
has been shown to inhibit the formation of toxic oligomers and to prevent the formation of 
amyloid aggregates for different disease proteins (Hartl, 2011). More importantly, HSP70 
overexpression was reported to prevent muscle atrophy by inhibiting the transcriptional 
activation of the E3 ligases, atrogin-1 and MuFR-1 (Senf, 2008). HSP70 overexpression also 
ameliorates dystrophic pathology in mice (Gehrig, 2012).  On the basis of these findings, the 
pharmacological up-regulation of chaperone function promises to open new strategies for 
treating pathological states associated with aberrant protein folding and aggregation. However, 
a direct link between chaperone function and stem cell aging has not yet been demonstrated. 
To this end, I intended to study the link between chronic inflammation and proteostasis within 
skeletal muscle to determine whether compromised protein turnover is the mechanism by which 
chronic inflammation impairs muscle stem cell functionality and regenerative potential of aged 
muscle.  
 
Results 
Aged muscle accumulates ubiquitinated proteins, which can be removed by inhibition of 
inflammatory signals. 
 First, I evaluated the amount of ubiquitinated proteins in young and aged muscles by 
western blot as a crude indicator of ubiquitin-proteasome-dependent protein degradation level. 
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Ubiquitin antibody detected all ubiquitin conjugates in the protein extracts of young and aged 
muscle tissue, and showed greater amount of ubiquitinated proteins in aged mice (n=7; Figure 
29a). This result also confirms previous studies in rat (Altun, 2010;!Murata, 2011; Clavel, 2006). 
Moreover, overexpression of HSP72, an inducible isoform of HSP70, drastically reduced 
ubiquitinated protein levels in muscles (n=4, Figure 29b), which might imply that stabilization of 
protein folding by overexpression of chaperone protein reduces accumulation of misfolded 
proteins and thereby decreases the need of their clearance by the ubiquitin-proteasome 
pathway.  
 Ubiquitinated-protein level was also compared in muscles of young and aged IL-6 KO and 
age-matched WT mice in order to see if decreased systemic inflammation has any effect on 
ubiquitin-proteasome activity. IL-6 KO and WT mice did showed no difference in ubiquitinated-
protein level at young age, but when aged, IL-6 KO mice accumulated less ubiquitinated-protein 
compared to aged WT (n=4, Figure 29b,c). Based on previous studies that pointed to IL-6 as a 
potent driver of proteolysis in muscle (Bodell, 2009; Strassmann, 1992; Schaap, 2006), it is 
possible that depletion of IL-6 diminished proteolytic activity in aged mice by preventing hyper-
activation of the ubiquitin-proteasome pathway. The low inflammatory state of IL-6 KO mice was 
confirmed by decreased NF-κB activity in muscle measured by EMSA (n=5, Figure 30). In 
addition, HSP72-overexpressing mice showed inhibited transcriptional activity of NF-κB activity 
in muscle (Figure 30), as previously reported in a rat study (Senf, 2008). These data provide a 
line of evidence that low inflammatory state correlates with reduced level of ubiquitinated 
proteins during aging.  
 Accumulation of ubiquitin conjugates could be attributable to multiple factors—changes in 
the overall rate of protein ubiquitination in relation to the level of protein damage and misfolding, 
catalytic activity of the proteasome, or efficiency of deubiquitination. For complete 
understanding of the age-dependent regulation of ubiquitin-proteasome-dependent protein  
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degradation in muscle and possible role of HSP72 in the process, expression and activity level 
of proteasomes subunits, such as 20S and 19S, in these mouse models need to be analyzed. 
 
Regulation of HSP72 expression does not change with age.  
 Next, I asked if chaperone proteins are regulated differently in young and aged mice. As 
previous studies have shown that inhibition of proteasome activity induces HSPs (Bush, 1997; 
Kim, 1999), I postulated that the expression level of HSPs in muscle could be indicative of 
proteasome activity. HSP72 mRNA and protein levels in muscle tissue were not different in 
young and aged mice (n=5, Figure 32a,b). Likewise, mRNA levels of HSP72 in satellite cells 
isolated from young and aged mice were similar (n=5, Figure 32c). In addition, since HSP72 
expression is strongly up-regulated by cellular stress, induction of HSP72 mRNA level after 
cardiotoxin injury in young and aged muscle was also compared.  Both young and aged mice 
showed a similar increase in HSP72 expression after injury, as shown in Figure 31d (n=6). 
Thus, injury-associated regulation of HSP72 does not appear to change with aging. Expression 
levels of other proteins in the HSP family (HSP90, HSP60, HSP27, HSF, αB-crystallin) were 
also measured in young and aged muscle by qPCR and western blot, but no change was 
detected (data not shown).  
Taken together, these data indicate that aged mice show increased levels of 
ubiquitinated proteins in muscle without changes in HSP72 expression. This result suggests that 
accumulation of ubiquitinated protein in aged muscle could reflect a failure to upregulate 
chaperone proteins in response to increasing demand from damaged and misfolded proteins. 
To test this possibility, I tested if increased expression of chaperones, particularly HSP70, in 
muscle is able to prevent muscle atrophy or reverse the age-related decline in muscle function 
by stabilizing proteostasis of muscle proteins. 
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Overexpression of HSP72 does not affect regeneration or maintenance of skeletal 
muscle.  
A transgenic mouse model designed to globally overexpress HSP72 under the CMV promoter 
(HSP72-tg) was utilized to test if HSP72 has protective role in muscle.  Up-regulation of HSP72 
in the transgenic mice was validated by qPCR and western blot (Supplemental figure 11). 
HSP72-tg mice did not show a significant difference in muscle development or muscle mass at 
young age (Supplemental figure 12).  
 First, the potential role of HSP72 in muscle atrophy was studied by inducing atrophy 
through denervation in the hindlimb of HSP72-tg and WT mice. Motor innervation is known to be 
an important regulator of skeletal muscle mass and function, and denervation was reported to 
induce muscle atrophy through mechanisms involving the activation of FoxO and E3 ubiquitin 
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ligases (Tang, 2014). Animals were denervated by removing sciatic nerve, and changes in the 
mass of hindlimb muscles were measured 7, 14, and 21 days after denervation. Denervation 
caused significant loss of muscle mass in both HSP72-tg and WT mice, and the degree of 
muscle mass was not different between the two groups of mice at day 7, 14, or 21 after 
denervation (Figure 33a,b,c). Overexpression of HSP72 was not able to delay or hinder 
denervation-induced muscle atrophy.  
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 Muscle regeneration after cyoinjury and satellite cell function of young HSP72-tg mice was 
also evaluated (Figure 34). HSP72-tg mice exhibited a higher frequency of regenerating 
myofibers of greater cross-sectional size as compared to WT littermates at earlier time point 
after injury (day 5), possibly due to facilitated protein recovery after muscle damage (n=6, 
Figure 34a). However, this difference disappeared as muscle regeneration progressed (n=7,4; 
Figure 34b,c). Satellite cells of HSP72-tg mice were not distinguishable from satellite cells of 
WT mice in terms of satellite cell frequency, colony formation efficiency, or in vitro proliferation 
(n=8; Figure 33d,e,f). Also, GFP+ satellite cells transplanted into HSP72-tg mice showed 
indistinguishable numbers of engrafted myofibers as compared to WT controls (n=4, Figure 
33g). Studies of Hsp70-/- mice reported smaller myofiber size in resting muscle and severely 
impaired muscle regeneration after injury due to delayed inflammatory response, but no 
significant compromise in markers of satellite cell activation and proliferation in injured muscles 
(Senf,  2013). Potential role of HSP72 in recruitment of inflammatory cells in muscle after injury 
could explain the temporal improvement in muscle regeneration in HSP72-tg mice at day 5 after 
injury, when proper pro- and anti-inflammatory response is essential. On the other hand, HSP70 
does not appear to play a critical role in myogenic progression of satellite cells. Interestingly, 
HSP72-tg mice showed significantly increased latency to fall in wire-hang test, indicating overall 
muscle strength and function is improved with HSP72 overexpression (Supplemental figure 13). 
Since the outcome of hanging performance of mice is through coordination of multiple aspects 
of muscle function, further study is necessary to understand the advantageous role of HSP72 in 
this context. 
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Life-long overexpression of HSP72 does not protect muscle from age-related 
dysfunctions. 
Beneficial effects of HSP72 overexpression might not stand out at young age, because young 
muscles are not exposed as much to proteotoxic insults as aged muscles. For this reason, 
HSP72-tg mice were aged for 24 month in order to examine if HSP72 helps preventing 
sarcopenic symptoms. In aged mice, however, life-long overexpression of HSP72 was not 
sufficient to enhance the regenerative capacity of aged muscle as shown by regeneration of 
myofibers after cryoinjury (Figure 34c). The frequency and colony formation efficiency of 
satellite cells exhibited a slight trend of improvement, but the difference did not reach the level 
of statistical significance (Figure 35a,b). Although unexpected, it is possible that the role of 
HSP72 in recruiting inflammatory cells to damage site is no longer beneficial for muscle 
regeneration when muscle is chronically inflamed, as in aged mice. 
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Discussion 
Thus far, I have studied the potential role of HSP72 as a protective molecule combatting 
NF-κB-mediated protein degradation in aged muscle. In fact, increased ubiquitin conjugate level 
was detected in aged muscle, suggesting activated ubiquitin-proteasome proteolytic pathway. A 
previous study suggested that as aged muscle adapts to increased protein damage and 
misfolding, ubiquitin-proteasome proteolytic pathway becomes hyper-activated, eventually 
leading to collapse in proteostasis (Altun, 2010).  
The associations between molecular chaperones and the ubiquitin–proteasome system 
represent a critical step in the response to proteotoxic damage. Whether attempts should be 
made to refold damaged proteins or degrade them instead requires a consideration of cellular 
economy. Defects in the quality-control mechanisms may have enormous consequences even if 
only slight imbalances occur between protein folding and degradation, as these imbalances can 
cause accumulated toxicity over time. Modulation of this system may provide a unique 
therapeutic target for degenerative diseases and pathologies associated with aging. This study 
has focused on the role of HSP70, as it is known to regulate NF-κB activity and is relatively well 
studied in muscle tissue, but the involvement of other HSP families in muscle aging, maybe in 
collaboration with HSP70, would also be interesting to study.  
Regulation of HSP72 expression was shown to remain unchanged with age. Considering 
the basic role of HSP72 as a chaperone assisting protein folding, I tested if up-regulation of 
HSP72 helps to maintain muscle tissue. Global overexpression of HSP72 reduced NF-κB 
activity in muscle, but it was not sufficient to prevent muscle atrophy induced by denervation. In 
the case of disuse atrophy, however, overexpression of HSP70 prevented muscle loss by 
inhibiting NF-κB and Foxo3a activity (Senf, 2008). It is conceivable that the mechanism of 
muscle atrophy is different depending on how it is induced. Preventive role of HSP72 in age-
related muscle atrophy is to be studied. 
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Muscle regeneration at early stages appeared to be improved in young HSP72-tg mice, 
possibly due to facilitated immune response as previously studied (Senf, 2013), but such an 
effect was not observed in aged HSP72-tg mice. As inadequate and excessive inflammatory 
response is often attributed to delayed muscle regeneration in aged mice, increased recruitment 
of inflammatory cells by up-regulated HSP72 might have adverse effects on regeneration of 
aged muscle.  
Satellite cell function was not affected by HSP72 expression at any age examined here. 
A recent study in the hematopoietic system reported an important role of the autophagy-
lysosome pathway in maintaining HSC pool in old mice by protecting HSCs from metabolic 
stress. However, satellite cells of young and aged mice in this study did not show any difference 
in mRNA expression of essential genes involved in autophagy (ulk1, atg5, atg7, foxo3a) (data 
not shown). As quiescent satellite cells directly isolated from mice show low  metabolic activity, 
further analysis on autophagic activity of proliferating or differentiating satellite cells should be 
done. It will be important to characterize the mechanisms that regulate proteostasis in muscle 
stem cells to determine if they differ from those in other cells and to assess how they may 
influence changes in stem cell function during aging. 
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Chapter 6. 
Conclusions and discussion: 
Prevention of chronic inflammation for healthy aging 
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Sarcopenia, the age-related loss of muscle mass, is a direct cause of an age-related 
decrease in muscle function that has an immediate impact on the quality of living in the old age. 
Decline in the regenerative capacity of muscle due to a decrease in functional satellite cell pool 
has been considered as one of reasons causing age-related muscle wasting. Based on previous 
studies showing the impact of aged systemic milieu on regenerative potential of muscle and 
other tissue functions (Conboy, 2003; Conboy, 2005b; Vileda, 2011; Loffredo, 2013; Elabd, 
2014; Sinha, 2014; Katsimpardi, 2014), this study focused on the role of chronic inflammation in 
aging of satellite cell pool. Unproductive, low-grade chronic inflammation, characterized by up-
regulation of the inflammatory responses due to the chronic antigenic stress that impinges 
throughout life upon innate immunity, has been implicated in the onset of many age-associated 
chronic diseases, including sarcopenia. In this notion, this study aimed to discover the molecular 
mediators of chronic inflammation and their mechanisms of action in the age-related decline in 
regenerative capacity of muscle. As a result, this study showed age-dependent up-regulation of 
NF-κB activity in muscle tissue, and discriminated the impact of NF-κB elevation/inhibition in 
skeletal muscle fibers versus satellite cells, and revealed a non-autonomous regulation of 
satellite cell regenerative function by NF-κB driven gene expression in regenerating myofibers. 
This result corroborates the importance of muscle stem cell niche, or microenvironment, in 
regulation of satellite cell function. It was also demonstrated that systemic inhibition of NF-κB 
activity promotes more robust muscle regeneration in aged animals, suggesting salicylate 
treatment as a potential therapeutics for sarcopenia.   
In order to further dissect the molecular mechanism of non cell-autonomous effect of NF-
κB in muscle, gene expression pattern in whole muscle of young and aged WT, and aged MISR 
mice was compared. Candidate genes that are differentially expressed between young and 
! 84!
aged WT muscle and also between aged WT and aged MISR muscle were validated and tested 
for their potential role in muscle regeneration. As a result, group V phospholipase A2, PLA2G5, 
was identified as a molecular mediator of age-dependent elevation of NF-κB activity, extending 
understanding of the pathophysiology of age-related loss of muscle regenerative capacity, and, 
at the same time, opening a new insight into the cross-regulation of lipid metabolism and muscle 
maintenance. Further study is required to clarify how PLA2G5 incurs inflammatory tone in 
muscle. Prostaglandins, enzymatically driven from fatty acids by phospholipase A2, have been 
known to regulate inflammation; and COX-2, an enzyme responsible for intermediate steps in 
sequential oxidation of arachidonic acid to produce prostaglandins, is the drug target of currently 
available non-steroidal anti-inflammatory drugs. Especially prostaglandin E2 (PGE2) has been 
implicated in muscle wasting which suggests PGE2 as an intriguing candidate to study for its 
potential role in satellite cell function (Standley, 2013).  
 In addition, this study revealed a restrictive role of IL-6, one of target genes of NF-κB 
and a pro-inflammatory cytokine widely observed as a biomarker of chronic inflammatory state 
of aged individuals, in the myogenic function of satellite cells. Global depletion of IL-6 improved 
satellite cell function and muscle regeneration in young mice; however, in aged mice, life-long 
depletion of IL-6 was not able to rescue impaired muscle regeneration even though satellite cell 
function was still enhanced. I conclude that this distinct effect of IL-6 depletion in young and old 
age is due to mature-onset obesity and obesity-induced diabetes in aged mice with IL-6 
depletion. This result suggests an unexpected role of IL-6 in energy metabolism. Previously 
Wallenius et al. reported the anti-obesity effect of IL-6 is mainly exerted at the level of the 
central nervous system, possibly in the hypothalamus (Wellenius, 2002). It is possible that IL-6 
has different effects on different tissues, and for this reason, it needs to be considered that there 
may be a small therapeutic window between the doses needed for beneficial effects and those 
associated with adverse effects and illness. 
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In parallel, HSP72 was studied as a part of the molecular pathway for inhibition of 
chronic inflammation or for mitigation of the damaging effects of chronic inflammation in muscle. 
Overexpression of HSP72 appeared to decrease protein degradation activity along with reduced 
NF-κB activity; however, it was not sufficient to improve the regenerative function of aged 
muscle or aged satellite cell. Based on previous reports about the beneficial effect of HSP72 in 
prevention of disuse atrophy (Senf, 2008), it is conceivable that HSP72 has a cytoprotective role 
in situations when muscle cells are undergoing excessive, unnecessary protein degradation. 
However, during muscle satellite cell proliferation/differentiation and myofiber growth when 
protein synthesis is expected to exceed protein degradation, the protective role of HSP72 might 
not be as prominent. In fact, treatment with BGP-15, a pharmacological inducer of Hsp72 
currently in clinical trials for diabetes, improved muscle architecture, strength and contractile 
function in severely affected muscles of mdx dystrophic mice, by protecting fragile myofibers 
susceptible to an influx of Ca2+ (Gehrig, 2012). Although overexpression of HSP72 does not 
seem to be advantageous for satellite cell function and muscle regeneration, other aspects 
required for proper function of muscle, such as intact neuromuscular junction and energy 
metabolism, in HSP72-overexpressing mice might reveal additional role(s) of HSP in muscle. 
Also, regulation of protein homeostasis by other molecules or pathways in satellite cells, both 
quiescent and differentiating, in young or old mice, needs to be studied in order to understand 
the potential role of protein quality control in maintenance of functional satellite cell pool. 
Thus far, I discussed about the impact of chronic inflammation and its molecular 
mediators and inhibitors on the regenerative capacity of aged muscle. The ultimate goal of 
uncovering the molecular basis of age-related chronic inflammation would be to develop a 
therapeutic strategy for improvement of muscle health and prevent muscle degeneration in 
patients or older individuals. A number of currently available regimens are suggested to promote 
healthy function during aging and to counteract chronic inflammation. Caloric restriction, for 
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example, decreases accumulation of metabolic byproducts such as reactive oxygen species, 
which have the ability to activate cell signaling cascades that include IκB kinase and MAPKs 
and initiate pro-inflammatory responses (Kim, 2000). Thus, caloric restriction delays the 
biological rate of aging and extends lifespan in a variety of organisms from yeast to primates, 
and protect against age-associated diseases including chronic inflammatory disorders such as 
cardiovascular disease and diabetes (González, 2012). A previous study from the Wagers lab 
showed increases the frequency and function of skeletal muscle stem cells in both young and 
old mice after short-term calorie restriction, potentially by increasing mitochondrial content and 
promoting oxidative metabolism (Cerletti, 2012).  
Physical exercise is also well recognized as an important strategy for reducing the risk of 
chronic diseases, and many studies have been done to investigate its role in the improvement 
of the inflammatory profile (Beavers, 2010). Large population-based cohort studies consistently 
show an inverse association between frequency of physical activity and markers of systemic 
inflammation such as C-reactive protein (CRP), IL-6, and fibrinogen, in old age (Taffe, 2000; 
Reuben, 2003; Elosua, 2005). Although specific molecular mechanisms underlying the 
beneficial effects of exercise is still under active investigation, physical exercise is a promising 
strategy for reducing chronic inflammation. Also, changes in systemic inflammatory tone caused 
by physical activity stress an additional function of skeletal muscle as a secretory organ. As the 
largest organ in the body, skeletal muscle is capable of largely impacting the systemic milieu 
and communicating with other organs such as adipose tissue, liver, pancreas, bones, and brain, 
by its secretory phenotype. In this view, elevated NF-κB activity in aged muscle tissue would 
have global influence, in addition to the detrimental impact on local environment, contributing to 
systemic inflammation in aging animals. 
These anti-inflammatory regimens are clearly capable of improving the overall health 
status of subjects, but development of therapeutic treatment for muscle wasting is also crucial 
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for sarcopenic/atrophic individuals whose physical and nutritional status is not suitable for 
restriction of calorie intake or frequent physical activity. For this purpose, elucidating the 
molecular profile, especially the secretory profile in skeletal muscle, underlying these anti-
inflammatory regimens will be useful for mimicking the beneficial effects. I believe that NF-κB 
signaling pathway and its downstream and upstream effectors in muscle investigated in this 
study will not only provide potential targets for improving skeletal muscle regeneration but also 
further help to extend the healthspan of older adults and patients.   
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Chapter 8. 
Materials and methods 
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Animals  
Young (2–3 month) and aged (24–26 month) C57BL/6 mice were obtained from 
pathogen-free breeding colonies at Jackson Laboratories and Charles River Labs. MISR 
(obtained from Dr. Steven Shoelson; Cai, 2004), Pax7Cre-ER mice (Nishijo, 2009), IL-6 KO 
(C57BL/6;129S2-Il6tm1Kopf/J; Kppf, 1994) mice, and GFP transgenic mice (C57BL/Ka-β-actin-
EGFP; Sherwood, 2004; Cerletti, 2008; Cerletti, 2012) were bred in house; flox-STOP-flox IKK 
mice (C57BL/6-Gt(ROSA)26Sortm1(Ikbkb)Rsky/J) were purchased from Jackson Labs. HSP72 
over-expressing mice (initially obtained from Dr. Mark Febbraio) were successfully back-crossed 
for at least nine generations to C57BL/6 mice.  
Fidelity of the Pax7-CreER line for satellite cell-specific gene expression has been 
validated previously (Nishijo, 2009). Tamoxifen (0.1 mg / g body weight) or corn oil vehicle (10 
µl /g body weight) was injected for 5 consecutive days after two weeks of sodium salicylate 
treatment. For sodium salicylate treatment, a feed containing 3 grams of sodium salicylate 
(Sigma Aldrich) per kg was created by Research Diets, and purchased along with control feed 
with the same nutritional content but lacking salicylate. Mice were provided sodium salicylate or 
control feed ad libitum for 6-8 weeks prior to experimentation. For IL-6 Injection, mice were 
injected with 300 pg/kg human recombinant IL-6 (Peprotech). IL-6 was dissolved in PBS to 
16ng/ml, and a volume of 25µl was injected daily. Control mice were injected with PBS.  
Animals were housed at the Biomedical Research Institute at Harvard University and 
animal facility at the Joslin Diabetes Center. All mice were housed and treated under approved 
protocols by relevant Institutional Animal Care and Use Committees.  
 
Satellite cell Isolation 
Single myofibers and myofiber-associated cells were prepared from intact limb muscles 
(extensor digitorum longus, gastrocnemius, quadriceps, soleus, tibialis anterior, and triceps 
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brachii), as previously described (Cerletti, 2008; Cerletti, 2012; Sinha, 2014). After isolation, all 
myofiber-associated cells were incubated in Hank’s Buffered Salt Solution (Gibco) containing 
2% donor bovine calf serum on ice for 20 min with the following antibodies: 30-F11 (1:200, anti-
mouse CD45, phycoerythrin (PE) or allophycocyanin (APC) conjugate (eBioscience, San Diego, 
CA)); M1/70 (1:200, anti-mouse CD11b, PE conjugate, (eBioscience); or 1:800, anti-mouse 
CD11b, APC conjugate, (eBioscience)); D7 (1:800, anti-Sca-1, Ly-6A/E, APC conjugate 
(eBioscience)), β1-integrin (1:200, anti-mouse CD29, purified, (BD Pharmingen, San Jose, CA; 
or 1:400, anti-mouse/rat CD29, PE conjugate (Biolegend, San Diego, CA); CXCR4 (1:100, 
biotinylated anti-mouse CD184 (BD Pharmingen)), Streptavidin (1:100, Cy7-PE conjugate 
(eBioscience)), anti-armenian hamster IgG, fluorescein isothiocyanate (FITC) conjugate (1:100, 
eBioscience). Muscle stem cells, identified as CD45−Sca-1−Mac-1−CXCR4+β1-integrin+ were 
sorted by Fluorescence Activated Cell Sorting (FACS) (Cerletti, 2008; Cerletti 2012). Previous 
studies have shown that >95% of CD45−Sca-1−Mac-1−CXCR4+β1-integrin+ cells express Pax-7 
(Cerletti, 2008). Live cells were identified as calcein blue positive (1:1000, Invitrogen, Carlsbad, 
CA) and propidium iodide negative (PI, 1mg/mL). Satellite cells were double-sorted to maximize 
purity (Cerletti, 2012). 
Flow cytometry and cell sorting were performed at the Joslin Diabetes Center or HSCRB 
Flow Cytometry Cores. Sorting and analysis were carefully optimized for antibody titration and 
to achieve maximal cell purity and viability.  
 
Myogenesis assays  
For evaluation of myogenic function of satellite cells, colony formation assay and 
differentiation assay was performed. Formation of myogenic colony was used as a 
measurement of stem cell functionality of satellite cells to survive, self-renew and proliferate in 
culture. A single CD45−Sca-1−Mac-1−CXCR4+β1-integrin+ satellite cell was seeded in each well 
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of collagen/laminin-coated 96-well plate. In order to coat the plates, wells were exposed to PBS 
containing 1µg/ml of collagen (Sigma) and 10µg/ml of laminin (Invitrogen) for at least one hour 
and then were briefly air-dried before addition of cell culture growth medium (F10, 20% horse 
serum, 1% Glutamax and 1% pen/strep) and 5ng/ml of bFGF (Sigma, St. Louis, MO).  
Afterwards, cells were cultured for 5 days at 37°C, with daily supplement of bFGF. Colony 
formation efficiency was analyzed using bright field microscopy on day 5 of culture as the 
percent of seeded wells that contained cell colonies.  
For differentiation assays, satellite cells were sorted into coated 96-well plates at 3000 
cells per well. Cells were cultured in growth media described above supplemented with bFGF 
for 5 days. At 5 days after plating, media were changed to differentiation media (DMEM, 1% 
GlutaMax, 1% pen-strep, and 2% horse serum) and cultured for an additional 2-3 days to allow 
proliferated satellite cells and myoblasts to differentiate and fuse to form myotubes. Myotubes 
were stained with anti-fast myosin (Sigma), and DAPI for myonucleus. Images were acquired 
using a Zeiss Observer D1 inverted microscope.  
 
Quantitative RT-PCR  
For RNA extraction, CD45−Sca-1−Mac-1−CXCR4+β1-integrin+ satellite cells were 
deposited in Trizol (Invitrogen) and muscle tissues were homogenized in Triozol by Gentle 
MACS Dissociator (Miltenyi Biotech). cDNA was prepared using Superscript III Reverse 
Transcriptase Supermix Kit (Invitrogen). Real-time quantitative PCR was performed in an ABI 
7900 machine (Applied Biosystems), using SYBR Green PCR mix (Quiagen). β-actin and hprt 
was used as a housekeeping gene, and gene expression levels were normalized to β-actin 
expression. Primers sequences are provided in Appendix (Table 2). 
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Electrophoretic mobility shift assay (EMSA)  
All nuclear extraction procedures were performed on ice with ice-cold reagents. Nuclear 
protein was extracted from muscle tissue homogenized by glass Dounce homogenizers and 
Nuclear Extraction Kit from Panomics. Protein concentration of nuclear extract was measured 
using the BioRad DC Protein Assay (BioRad). Nuclear extracts were prepared for gel shift 
experiments by preincubating protein with poly(dI–dC) and either a biotin-labeled double-
stranded oligonucleotide having consensus recognition sequences for NF-κB (5’-
AGTTGAGGGGACTTTCCCAGG-3’) and Oct-1 (5’-GTCGAATGCAAATCACTAGAA-3’) 
(Panomics).  Unlabeled probe was used as negative control, and nuclear extract prepared from 
HeLa cell line with stimulation of NF-κB activity was used for positive control (Panomics). 
Protein-DNA complexes were allowed to form for 30 min at 15°C, and the complexes were run 
on a native 5% TBE polyacrylamide gel (Criterion) and then transferred onto a Biodyne B nylon 
membrane (Pall).  Oligos were fixed to the membrane by heat (80°C) for 1hr and then blocked 
and prepared for detection by streptavidin-horseradish peroxidase (HRP) solution according to 
the Panomics EMSA Detection Kit.  Finally, membranes were exposed using enhanced 
chemiluminescence (ECL) Plus (Amersham). Results were visualized by autoradiography and 
quantified using Image J densitometry. 
 
Tissue injury and quantification of regenerating myofibers  
For cardiotoxin Injury, mice were anesthetized by isoflurane inhalation and a dose of 
25µl of 0.03 mg/ml Naja mossambica mossambica cardiotoxin (Sigma) was injected directly into 
the tibialis anterior (TA) muscle using an insulin syringe. For cryoinjury, mice were anesthetized 
and a small piece of dry ice with flat surface was applied directly to exposed TA muscle for 5 s. 
The skin incision was closed with suture immediately after injury. This procedure generates a 
reproducible “wedge‟ injury in the muscle with a discrete border between uninjured and injured 
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muscle, and this border remains clear and distinct during regeneration of the injured tissue. 
Injured muscles were allowed to recover for 5, 7, 14 days before harvest. For quantification of 
muscle regeneration after injury, harvested muscles were fixed in 4% paraformaldeyhyde for 90 
minutes and washed in PBS for paraffin sections, or frozen for frozen sections (10µm). Sections 
were stained with hematoxylin and eosin (H&E), and a series of pictures panning across the 
regenerating area in the cross-section at the middle belly of injured muscle was taken. Size of 
150 representative regenerating myofibers with centrally located nuclei in injured muscle was 
blindly measured from 4 slides with 3 consecutive sections in each slide, using Axiovert 
software (Carl Zeiss Microscopy). 
 
Single cell gel electrophoresis assay (Comet assay) 
3000 satellite cells were double-sorted into Eppendorf tubes containing 350µl of Hank’s 
Buffered Salt Solution (Gibco) with 2% donor bovine calf serum, and comet assay was 
performed according to manufacturer’s specifications (Cell Biolabs, Inc.). Cells were centrifuged 
at 700 rcf for 4 minutes at room temperature and the cell pellet was resuspended with low-
melting point agarose gel pre-incubated at 37°C for at least 20 min. The cell-agarose 
suspension was then applied onto the comet slides gently and allowed to form a thin layer. The 
agarose layer was further solidified on ice before submersion in lysis buffer (Cell Biolabs, Inc.). 
Cell lysis was carried out 16-18 hours at 4°C and comet slide was then electrophoresed in 
alkaline electrophoresis buffer. Extreme care was taken to minimize exposure to light during 
sorting and subsequent processing and handling of cells until electrophoresis. Finally, 
electrophoresed DNA was stained with VistaDye and visualized using a Zeiss Imager M1 
Fluorescence microscope (Carl Zeiss). Approximately 300 comets per animal were visually 
scored using a 3-point ranking scale and according to published protocols (Collins, 2004). This 
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scoring approach has been documented to be equally effective for detecting differences as 
other methods (e.g. calculation of tail moment) (Collins, 2004). 
 
Immunofluorescence 
For immunofluorescence, cells or frozen muscle sections were fixed in 4% 
paraformaldehyde in PBS for 20 minutes and washed with PBS. Cells or muscle sections were 
permeabilized and blocked using 2% BSA / 0.5% Goat Serum / 0.5% Triton-X in PBS for 60 
minutes at room temperature. For primary antibodies raised in mouse, the M.O.M 
immunodetection kit (Vector Laboratories) was used. Primary antibodies (mouse monoclonal 
anti-fast myosin (1:200, Sigma), anti-myod (1:50, Santa Cruz) were incubated with samples for 
12-16 hours at 4°C, and secondary antibodies (1:200, AlexaFluor 555, AlexaFluor 488 or 
AlexaFluor 594 Invitrogen) for 60 minutes at room temperature (with 3-4 washes in PBS 
following each incubation). All samples were mounted on slides in Vectashield mounting 
medium containing DAPI (Vector Laboratory). Fluorescence images were obtained using a 
Zeiss Imager M1 Fluorescence microscope (Carl Zeiss) and quantified using ImageJ.  
 
RNA transcriptome analysis  
Total RNA was extracted from muscle tissue using Trizol (Invitrogen). The quality of 
RNA was assessed with a 2100 Bioanalyzer (Agilent Technologies). RNA transcriptome 
analysis was performed using Gene chip WT PLUS reagent kit (Affymetrix) and Mouse Gene 
2.0 ST arrays (Affymetrix). The dataset was normalized by RMA algorithm. A subset of 
differentially expressed myogenic transcripts was chosen to generate a heatmap from the 
original dataset normalized by gcRMA algorithm and SAM cutoff (<10% q-values) using R 
statistical software.  
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In vivo electroporation 
TA muscles subjected to in vivo electroporation were pre-conditioned by injection of 10 
ul of 2 mg/ml hyaluronidase solution 1 hour prior to electroporation. Mixture of 50 pmol of siRNA 
(Life Technologies) and 30 ug of mCherry-expressing plasmid (Addgene) in 10 ul of PBS was 
injected into the pre-conditioned muscles and was allowed to wait 10 minutes before 
electroporation. Electrodes were protruded into each ventral end of TA muscle and 
electroporation was performed by applying 10 pulses, 50 ms in duration/each, at 1Hz. This 
procedure was repeated with negative control siRNA (Life Technologies) on the contralateral 
muscle. 
 
Satellite cell transplantation    
TA muscles of recipient mice were injured (25µl dose of 0.03mg/ml cardiotoxin) one day 
prior to injection in order to facilitate engraftment of fluorescent satellite cells.  The next day, 
double-sorted satellite cells isolated from GFP transgenic mice, and recipient mice received 
5000 double-sorted GFP+ satellite cells per TA muscle.  Four weeks post-transplant, TAs were 
harvested and promptly frozen in 2-methylbutane cooled in liquid nitrogen. Frozen samples 
were serially sectioned throughout the TA muscle from tendon to belly using Microm HM550 
cryostat (Thermo Scientific).  For analysis, number of GFP+ fibers in each muscle section was 
counted to determine the maximum engraftment in each muscle. Muscle sections were 
analyzed blindly for maximum number of GFP+ fiber and cross-sectional area of engrafted fibers 
using Axiovision software (Carl Zeiss). 
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Western blot analysis  
Protein was extracted from whole muscle using Dounce homogenizers (Sigma) and 
COmplete Mini Protease Inhibitor Cocktail tablets (Roche) dissolved in M-PER protein 
extraction buffer (Pierce). Homogenates were centrifuged at 14,000g for 15min, after which the 
supernatant was removed for protein analysis.  Protein concentrations of samples were 
measured with the BCA Protein Assay (Pierce), and samples were heated to 100°C for 
denaturing in Laemmli Sample Buffer (Bio-Rad) and β-mercaptoethanol for 10min.  
Protein extracts were loaded on a 4–20% gradient Criterion Tris-HCl polyacrylamide gels 
(Bio-Rad) and then transferred to a PVDF membrane (Immuno-Blot, Bio-Rad). Membranes 
were blocked in 5% non-fat dry milk for 1h and were then stained at 4°C with primary antibody 
diluted 1:1000 in Tris-buffered saline (Atlanta Biologicals) with 0.1% Tween-20 and 5% milk. 
HRP-conjugated secondary antibodies (Santa Cruz) were diluted 1:2000 in 5% milk for 90min 
incubation at room temperature. Immunoblots were developed with an ECL plus system 
(Amersham) for visualization. A list of antibodies used is as follows: anti-GAPDH (ab9485, 
Abcam), anti-IL-6 (sc-1265, Santa Cruz), anti-HSP72 (adi-SPA-810-d, Enzo), anti-poly-Ubiquitin 
(Ab7254, Abcam), anti-Mouse IgG HRP Conjugated (sc-2005, Santa Cruz), Anti-Goat/Sheep 
HRP Conjugated (AB324P, Millipore). 
 
ELISA 
For ELISA, plasma harvested from young and aged mice were diluted as indicated and 
used on IL-6 ELISA kit (R&D System) as per manufacturer’s instructions. 
 
Wire hang test 
In order to assess whole-body muscle strength and endurance, mice were allowed to 
grip a wire mesh grid with all four limbs. The grid was then inverted and placed at a height of 35 
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cm above a padded surface. Latency-to-fall was recorded in three successive timed trials. Mice 
were subjected to this test three separate times over the period of one week.  
 
Treadmill exercise   
In order for mice to become accustomed to the treadmill-exercise environment, 
conditioning was conducted for three days in a row for 10min/day at speeds increasing from 
10m/min to 15.5m/min on a 15° upward incline.  After this period, mice were allowed one day of 
rest.  The following day, mice were run 15° uphill for one hour at 15.5m/min and then sacrificed 
immediately for whole muscle harvest.  
 
Denervation 
Mice were anesthetized under isoflurane. Skin incision was made at the dorsal part of 
left thigh and sciatic nerve was exposed by blunt dissecting the posterior thigh muscles. 
Exposed nerve was cut and the skin incision was sutured. For sham injury control, the skin 
incision was sutured without cutting the sciatic nerve. Hind limb muscles were harvested 7, 14, 
21 days after denervation and weighed to assess denervation induced muscle atrophy. 
 
Statistical analysis  
To determine statistical significance between experimental groups, I used the two-tailed, 
unpaired Student’s t-test and one-way ANOVA (Microsoft Excel, Prisom). Error bars in figures 
depict standard error of the mean (S.E.M.).  Stepdown-Bonferroni method was used for analysis 
of difference between size distributions of two difference groups of mice, and signed rank test 
was used for comparing for non-parametric, paired data. Statistical significance was set at p < 
0.05.  
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Appendix: Supplemental figures 
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Supplemental figure 3. Heat map generated for candidate genes from gene array analysis of muscle tissue from young WT, aged 
WT, and aged MISR. 
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Genes up-regulated in age WT, down-regulated in young WT, 
and down-regulated in aged MISR 
 Function 
NF-kB binding 
prediction 
Tmem100 Trans-membrane protein 0.86 
Grem2 Cytokine that inhibits the activity of BMP2 and BMP4 in a dose-dependent manner. Antagonized BMP4-induced suppression of progesterone production in granulose cells N/A 
Pgpep1l Pyroglutamyl-Peptidase 1-Like Protein; cysteine-type peptidase activity 0.96 
Fgfbp1 Fibroblast growth factor binding protein 1: interact with FGF-7, FGF-10, FGF-22 N/A 
Mab21l1 Required for several aspects of embryonic development including normal development of the eye N/A 
Kcnf1 Voltage-gated potassium channel subunit  N/A 
Scn3b Sodium channel subunit beta3 0.93 
Aebp1 Adipocyte enhancer binding protein1: May also positively regulate NF-kB activity in macrophages, leading to enhanced macrophage inflammatory responsiveness N/A 
Kcnab1 Potassium Voltage-Gated Channel, Shaker-Related Subfamily, Beta Member 1 0.91 
Mir1a-1 Posttranslational regulation of gene expression by miRNA 0.89 
Pla2g5 Phospholipase A2 group V. Secretion of this enzyme is thought to induce inflammatory responses in neighboring cells.  0.94 
Pla2g7 Phospholipase A2 group VII. Catalyzes the degradation of platelet-activating factor to biologically inactive products. 0.81 
Dkk3 Glycoproteins that antagonizes canonical Wnt signaling 0.84 
Cdkn2c P18-INK4C; G1 to S cell cycle reactome  N/A 
Cadm1 Cell adhesion molecule 1: mediates homophilic cell-cell adhesion in a Ca(2+)-independent manner;. 0.87 
Ostn Musclin: muscle-derived secreted factor.  Appears to modulate osteoblastic differentiation.  N/A 
Dusp26 Dual specificity phosphatase 26: Inactivates MAPK1 and MAPK3 which leads to dephosphorylation of heat shock factor protein4 and a reduction in its DNA-binding activity. Inhibits MAP kinase p38 N/A 
 
 
 
Supplemental table 1. Functions and NF-kB binding prediction of candidate genes selected from gene array analysis in muscle 
tissue of young and aged WT and aged MISR. 
 
Genes down-regulated in age WT, up-regulated in young WT, and up-regulated in aged MISR 
 Function 
NF-kB binding 
prediction 
Ccdc80 Promotes cell adhesion and matrix assembly 0.92 
Agbl1 ATP/GTP protein binding protein-like 1: metallocarboxypeptidase activity and tubulin binding N/A 
Nmrk2 Nicotinamide riboside kinase 2 0.99 
Sacs Co-chaperone which acts as a regulator of the Hsp70 chaperone machinery and may be involved in the processing of other ataxia-linked proteins; interact with NF-kB 0.86 
Plekho1 Pleckstrin homology domain containing familiy O member 1: regulation of the actin cytoskeleton through its interactions with actin capping protein. N/A 
Retnla Resistin like alpha: secreted protein, expressed in adipose tissue 0.83 
Terc Telomerase RNA component 0.98 
Nr4a3 A member of the steroid-thyroid hormone-retinoid receptor superfamily: nuclear receptor subfamily4 groupA 0.86 
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Supplemental figure 4. qRT-PCR analysis on candidate gene expression in young and old WT and MISR muscle for validation of 
gene array results. (Validated genes are highlighted) 
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Supplemental figure 5. Results from pooled screen analysis of candidate genes. siRNAs for each group of candidate genes were 
in vivo electroporated into TA muscles of aged mice in order to screen for genes that has impact on muscle regeneration. 
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Gene Forward primer Reverse primer 
Actb 5’-TTCTGGTGCTTGTCTCACTGA-3’ 5’-CAGTATGTTCGGCTTCCCATTC-3’ 
Il6 5’-GTTCTCTGGGAAATCGTGGA-3’ 5’-TCTGCAAGTTGCATCATCGTT-3’ 
Il33 5’-TGCGTCTGTTGACACATTGA-3’ 5’-STGTACTCAGGGAGGCAGGA-3’ 
Cox2 5’-TGAGCAACTATTCCAAACCAGC-3’ 5’-GCACGTAGTCTTCGATCACTATC-3’ 
Ccl2 5’-AAGAGGATCACCAGCAGCAG-3’ 5’-TCTGGACCCATTCCTTCTTG-3’ 
IL-6  5’-GTTCTCTGGGAAATCGTGGA-3’ 5’-TCTGCAAGTGCATCATCCGTT-3’ 
HSP72  5’-ACCAAGCAGACGCAGATCTTC-3’ 5’-GCCCTCGTACACCTGGATCA-3’ 
Myogenin 5’-CTACAGGCCTTGCTCAGCTC-3’ 5’-GTGGGAGTTGCATTCACTGG-3’ 
pla2g5 5’-CCAGGGGGCTTGCTAGAAC-’3 5’-AGCACCAATCAGTGCCATCC-’3 
Plekho1 5’-AATTCTGCGGGAAAGGGATTT-’3 5’-AACACCTCCTGACTGTTTTTCTC-’3 
Retnla 5’-CCAATCCAGCTAACTATCCCTCC-’3 5’-ACCCAGTAGCAGTCATCCCA-’3 
Nr4a3 5’-AGGATTCACTGATCTCCCCAA-’3 5’-GATGCAGGACAAGTCCATTGC-’3 
Ccd80 5’-CCTGCCTTGGATAGCGACAG-’3 5’-ACACTGGTACACTCTTCCTCC-’3 
Abgl1 5’-CCAGCAGTGCCTATACCTTCC-’3 5’-TGCTCAGATCAGTTTCCAAGTC-’3 
Sacs 5’-TCAGTTTGCCCCCTTCATTGG-’3 5’-CTGTAAGCGAAGAGGGAAACG-’3 
Dusp26 5’-ATGCCCTCTGTTCACCATCC-’3 5’-CTGTTGTGTGAGGCGTTGAG-’3 
Ostn 5’-CGTCTTGATGATCTGGTGTCC-’3 5’-TGGGAATACCAAACCGCTTTT-’3 
Pla2g7 5’-CTTTTCACTGGCAAGACACATCT-’3 5’-CGACGGGGTACGATCCATTTC-’3 
Aebp1 5’-TTGGAAACGCTGGATCGGTTA-’3 5’-CTTGACCTTGCCAGGCATTT-’3 
Cadm1 5’-GAACCAGCAGTTCACGATTCT-’3 5’-AGCAAGCATAGCATGGCAAAC-’3 
Cdkn2c 5’-CCTTGGGGGAACGAGTTGG-’3 5’-AAATTGGGATTAGCACCTCTGAG-’3 
Dkk3 5’-CTCGGGGGTATTTTGCTGTGT-’3 5’-TCCTCCTGAGGGTAGTTGAGA-’3 
Trem100 5’-GACAATGGAGAAAAACCCCAAGA-’3 5’-GGTAGCAGGAGAGTTCGGC-’3 
Mab21l1 5’-CCAAGCTGGTCTACCACCTG-’3 5’-GCGGTTCCTGCACTTCAAC-’3 
Grem2 5’-GGTAGCTGAAACACGGAAGAA-’3 5’-TCTTGCACCAGTCACTCTTGA-’3 
Kcnf1 5’-CGTGGCAGGCGAAGACATT-’3 5’-CCCCCGCCAAACAGTTGAT-’3 
Fgfbp1 5’-GGCAACTCAGGCGTTCTCA-’3 5’-CGTCAGAGATTTAGATGTCCTGC-’3 
Kcnab1 5’-AGGACCGACTTCTGAGCAAG-’3 5’-GATAGCGACAGTGCGGAATTT-’3 
Scn3b 5’-GATTGCTTCCCCTAGCTTCTCT-’3 5’-AGGAAATCTTTACCGCCCTCA-’3 
Pgpep1l 5’-AGGCCATCTTTCTGGAACAGT-’3 5’-GCCACTTCGACATTCTCAACAG-’3 
 
 
Supplemental table 2. List sequences of all primers utilized in qRT-PCR. 
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